Uptake, cellular fate and toxicity of engineered gold nanoparticles in A549 cells by Dosumu, Abiola Nneka
 
 
Uptake, Cellular Fate and Toxicity 
of Engineered Gold Nanoparticles 













A thesis submitted to the University of Birmingham for the degree of 









School of Biosciences 
College of Life and Environmental Sciences 





















This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 





Engineered gold nanoparticles (AuNPs) can be modified to produce functionalized AuNPs 
with potential biomedical applications. However, prior to medical use, an understanding of 
cellular uptake and fate is critical to assess their potential toxicity. 
This thesis studied 20 nm AuNPs coated with a luminescent ruthenium complex (RuS12) 
to form RuS12·AuNP20, which were fully characterised prior to cellular studies in A549 
cells treated for 2-72 hours.  
The size of internalised particles as quantified by transmission electron microscopy (TEM) 
was in agreement with characterisation data of particles in solution and particle size 
remained unchanged after up to 72hours treatment indicating non-aggregation of 
internalised RuS12·AuNP20. Particle number increased over time, and this was confirmed 
by quantitative analysis of confocal images, TEM and inductively coupled plasma mass 
spectrometry.  
Macropinocytosis and clathrin-mediated endocytosis were shown to be the route of uptake, 
with particles trafficked via the endo-lysosomal pathway as confirmed by co-localisation 
with fluorescent markers of early endosomes, lysosomes and autophagosomes in a time-
dependent manner that, ultimately involved autophagy as confirmed by western blotting of 
LC3 protein.  
Cellular accumulation of RuS12·AuNP20 also caused cellular changes related to oxidative 
stress including depletion of glutathione and DNA-strand breaks, but the mechanism of 
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1.1. Engineered Nanoparticles 
Nanoparticles are particles within the 1-100 nanometer (nm) scale, showing properties 
different from bulk samples of the same material (Auffan et al., 2009; Nel et al., 2006; 
Uboldi et al., 2009). The key point in defining nanoparticles lies in its dimensions; that is all 
three dimension of the particle are within the nanoscales (Murthy, 2007).  
The existence of nanomaterials can be traced back to Roman times. In Medieval Europe, 
what is now believed to be nanoparticles were used in stained glass currently observed in 
ancient churches (an example depicted in  
Figure 1) and nanotubes were also found in blades of swords made in Damascus used during 
the crusader war (Colomban et al., 2009; Horikoshi & Serpone, 2013; Jin et al., 2001; 
Reibold et al., 2006). However, the term nanoparticle was yet to be coined.  
                              
Figure 1: Rosace nord stained glass in the Cathédrale Notre-Dame de Chartres (France).  
Color changes depend on the size and shape of particles, which were made up of either gold (Au) or 
silver (Ag). Red triangle: ~ 100nm Ag; Yellow sphere: ~ 100nm Au; Green spheres: ~ 50nm Ag; Light 




The renowned physicist Richard Feynman in 1959 during a talk titled “There is plenty room 
at the bottom” first raised the scientific potential of nanoparticles and suggested engineers 
should go down to the bottom (nanoscale) and start from there (Appenzeller, 1991; 
Fitzpatrick et al., 2014). This talk is widely seen as the beginning of the study of 
nanoparticles, which became fully possible after the invention of powerful microscopes to 
enable the imaging of particles at nanoscale.  
Nanoparticles may occur naturally in soil, ground and surface water (Sharma et al., 2015). 
They can also be formed by naturally occurring activities such as wind erosion, weathering, 
volcanic activity, chemical-precipitation of naturally occurring chemicals and biomass 
combustion (in favorable conditions of temperature and oxygen) as shown in Figure 2 
(Hochella et al., 2015; Wang et al., 2013) however, most nanoparticles are man-made.  
       
Figure 2: Natural processes leading to the formation of nanoparticles in the environment 
 (Natural NPs – natural nanoparticles; T – temperature; O2 – oxygen) bottom-up approach 
starts from molecular/ionic species while the top-down approach starts from larger 
precursors. Figure taken from (Sharma et al., 2015). 
 
Man-made nanoparticles are referred to as anthropogenic nanoparticles and can be classified 
into two groups: non-engineered nanoparticles and engineered nanoparticles. Non-
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engineered nanoparticles are incidental by-products of human activities such as running 
diesels, fuels, erosions, welding, large-scale mining and combustion products (Handy & 
Shaw, 2007; Reinert et al., 2006). Non-engineered nanoparticles generally have widely 
distributed sizes and shapes and are a mixture of different elements (Contado, 2015) 
therefore they are heterogeneous in nature. In contrast, engineered nanoparticles (ENPs) are 
specifically synthesized usually by chemical reactions (Oberdorster et al., 2005). The design 
and synthesis of ENPs varies, and is dependent on it final applications (Kessler, 2011a). 
ENPs usually ranges in design and structure from solid spheres to tubes, rods, hollows and 
complex strands (Provenzale & Silva, 2009). ENPs are often polymers, carbon based, non-
metal, metals or metal oxide as shown in Figure 3. ENPs can also be made from biological 
molecules like phospholipids, lactic acid and dextran (De Jong & Borm, 2008; Maurer-Jones 
et al., 2013; Sharma et al., 2015; Tiede et al., 2008).  
                            
Figure 3: Representative types of ENPs (in green) and their origins (red).  
The origin of ENPs determines the type of ENPs. Example: ENPs made of metals are referred to as 
metallic ENPs with Ag and Au been the most common. Figure adapted from (Sharma et al., 2015). 
 
The increase in the synthesis of ENPs over the last decade is linked to the desire to take 
advantage of their unique electrical, optical, magnetic and catalytic properties associated 
with their nanoscale dimensions (Limbach et al., 2007; Sanvicens & Marco, 2008; Tonga et 
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al., 2014). The remarkable properties of ENPs are responsible for their various applications 
especially their unique large surface area to volume ratio (Auffan et al., 2008; Auffan et al., 
2009; Chen and Zhang, 1998; Dick et al., 2002; Kalantzi and Biskos, 2014). ENPs are 
currently being developed to target specific applications in various economic sectors: most 
notably: the chemical industry, structural engineering, textiles, electronics, consumer 
products and medical sciences (Bhatt & Tripathi, 2011; Linkov et al., 2009; Mazzola, 2003). 
ENPs can be either a final product or a component of a final product. Specific commercial 
applications of  ENPS includes sporting goods, tyres, stain-resistant clothing, sunscreens, 
sanitary ware coatings, toothpaste, food products and electronics (Heiligtag & Niederberger, 
2013; Hoet et al., 2004; Kessler, 2011b; Nel et al., 2006; Tsuji et al., 2006; Zhang et al., 
2015). In addition to these commercial applications, intensive research is geared towards the 
potential application and inherent risks associated with the use of ENPs in the health sector, 
which is discussed in details in this literature review.   
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1.1.1. Engineered Nanoparticles and Medicine. 
Engineered nanoparticles have remarkable potential in almost every branch of medicine 
ranging from oncology, cardiology, immunology, neurology, endocrinology, 
ophthalmology, pulmonary, orthopedics, to dentistry (Jain, 2008; Murthy, 2007). Recent 
investigation into specific use of ENPs in medicine includes:  
 Diagnosis,  
 Fluorescence biological imaging,  
 Probing of DNA structure, 
 Detection of proteins/gene, 
 Tumour destruction via heating (Hyperthermia),  
 Tissue engineering, 
 Gene and Drug Delivery (Cao et al., 2003; Giljohann et al., 2010; Nel et al., 2006; Pantarotto et 
al., 2004; Salata, 2004; Sanvicens & Marco, 2008).  
Therefore, the role of ENPs in medicine can broadly be classified into therapeutic and 
diagnostic roles (Kim & Hyeon, 2014; Zhang et al., 2008). As a therapeutic agent  ENPs 
have great potential for targeted delivery of drugs and genes to help overcome problems of 
drug safety and toxicity as well as crossing biological barriers (Burgess et al., 2010; Davis 
et al., 2008). ENPs as a diagnostic agent, allows detection at molecular scale, example is the 
identification of precancerous cells and disease markers that are difficult to detect via 
traditional diagnostic methods (Alharbi & Al-Sheikh, 2014; Solano-Umaña et al., 2015). 
1.1.1.1. Therapeutic Engineered Nanoparticles. 
Targeted delivery is one of the most important therapeutic application of ENPs. ENP can act 
as a delivery system that allows targeted delivery and controlled release (Caruthers et al., 
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2007; De Jong & Borm, 2008; Zhang et al., 2008). The rationale behind ENPs being a good 
delivery system lies in their physiochemical properties listed below. 
i. Ability to improve pharmaceutical and pharmacological property of drug, without 
causing drug degradation while ensuring reduced side effects (Peer et al., 2007; 
Singh & Lillard, 2009; Wilczewska et al., 2012).  
ii. Ability to cross (because of its nano-size) a range of biological barriers. Examples: 
fenestration of epithelial lining, endothelial and blood brain barrier as well as ability 
to penetrate deep into tissues through fine capillaries, accumulate in angiogenic 
tumour tissue to deliver drugs to target tissue/organ (Sung et al., 2007; Upadhyay, 
2014; Voigt et al., 2014). 
iii. Ability to deliver multiple types of therapeutics with different physiochemical 
properties (Kamaly et al., 2012; Panyam & Labhasetwar, 2003).  
iv. Ability to deliver a combination of imaging and therapeutic agents for real-time 
monitoring of therapeutic efficacy (Jo et al., 2016; Kamaly et al., 2012; Zhang et al., 
2008). 
Therapeutic ENPs are usually delivered to site of action, which in many cases are tumor by 
either active or passive targeting. In passive targeting, the ENPs accumulate preferentially 
to the tumor and inflammation sites via the enhanced permeability and retention (EPR) effect 
(Bazak et al., 2014). The EPR effect occurs when there is a disruption in the normal 
vasculature causing leaky blood vessels. Tumors, sites of inflammation, and diseased tissues 
are usually where EPR effects are observed, because of the compromise in their blood 
vessels compared to a normal blood vessels, thereby causing increased permeability due to 
openings which are absent in healthy tissues (Kobayashi et al., 2013). The EPR effect allows 
therapeutic ENPs to reach and persist in their target tissue/sites by passing readily from the 
blood vessels into tumor or inflamed tissue (Burgess et al., 2010) as shown in Figure 4: 
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Figure 4: Schematic illustration of nanoparticle accumulation in tumors  
A: passive mechanism via the EPR effect that allows preferential accumulation of nanoparticles near 
tumor tissue using leaky vasculature. B: Site-specific active tumor targeting through ligand-tumor cell 
surface receptor interactions. Figure taken from (Patel et al., 2012) 
 
In active targeting (also known as ligand-mediating targeting), bio-recognition molecules 
are attached to the surface of ENPs to target specific markers such as sugars or lipids or 
receptors that are overly expressed on the surface of the tumors usually and absent in healthy 
tissue (des Rieux et al., 2013; Yu et al., 2010). Bio-recognition molecules could be 
antibodies, proteins, peptides, nucleic acids, sugars or small molecules (Saha et al., 2010). 
This method of targeting tends to exhibit higher specificity, efficacy with decrease toxicity 
(Byrne et al., 2008; Singh & Lillard, 2009). 
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1.1.1.2. Diagnostic Engineered Nanoparticles.  
Although most of the applications of ENPs in medicine are directed towards therapeutic use, 
ENPs can also function as diagnostic agent specifically in imaging as nanoprobes. ENPs aim 
to improve the sensitivity and specificity in medical testing because they are well suited as 
a label for early diagnosis of diseases and biological testing (Rosi & Mirkin, 2005).  
Imaging has the ability to detect, quantify, and display molecular and cellular changes in 
vitro and in vivo non-invasively (Weissleder, 2006). The use of ENPs as nanoprobes offers 
them an advantage over routinely used fluorescent markers for diagnostic purpose. These 
advantages includes less photo-bleaching, better contrast enhancement and increased 
sensitivity (Chapman et al., 2013; Mirabello et al., 2015; Sahoo & Labhasetwar, 2003). The 
most commonly used ENPs for imaging are quantum dots (QD), magnetic nanoparticles and 
metallic nanoparticles such as gold and silver (Biju et al., 2008; Edmundson et al., 2014; 
Mirabello et al., 2015). For the purpose of this thesis, only gold nanoparticles (metallic 
nanoparticles) will be thoroughly discussed because they have demonstrated enormous 
feasibility in diagnosis and therapy of various different types of cancers (Huang & El-Sayed, 
2010) and are the subject of this research.   
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1.1. Gold Nanoparticles (AuNP) 
The discovery of AuNP was initiated by Michael Faraday when he wrote “gold is reduced 
to exceedingly fine particles which becoming diffused, produces a beautiful fluid of different 
colours” (Faraday, 1857). What Faraday observed 159 years ago is currently regarded as 
colloidal gold because they exhibited different characteristic from elemental gold. Colloidal 
gold, also known as gold nanoparticles (AuNP), is a suspension (or colloid) of nanometer-
sized particles of gold (Mody et al., 2010). 
AuNP have unique chemical and physical properties making them suitable as optical 
markers for medical diagnosis and drug delivery (Duncan et al., 2010; Gibson et al., 2007; 
Mieszawska et al., 2013; Paciotti et al., 2006). Certain characteristics of AuNP such as: ease 
of synthesis in the lab, stability, Surface Plasmon Resonance (SPR), ability to scatter light, 
facile bio-conjugation and ability to incorporate selectively with recognition molecules such 
as proteins, makes them attractive for biomedical applications specifically cancer diagnosis 
and therapeutic drug delivery  (Hu et al., 2006; Jain et al., 2008; Sokolov et al., 2003).   
The SPR of AuNP is responsible for most of its attractive properties. The SPR arises from 
free oscillating electrons on the surface of AuNPs, which can be excited by light of a specific 
wavelength. This excitation produces a collective coherent oscillation of the free electrons 
from the metal and a dipole oscillation along the direction of the field of light  (Huang & El-
Sayed, 2010). SPR is achieved when the amplitude of the dipole oscillating reaches a 
maximum at a specific frequency (Huang & El-Sayed, 2010; Huang et al., 2007).  
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Figure 4: Schematic illustration of Surface Plasmon Resonance   
The interaction of light of a specific wavelength with free electrons on the surface of metallic 
nanoparticles causes them to oscillate collectively in the direction of the electric field. Figure adapted 
from (Camacho, 2015). 
 
As the size of AuNP increases, the wavelength of the SPR also increases and there is a 
change in colour from red to purple as observed in the upper panel of Figure 5 (Murphy et 
al., 2008). SPR induces a strong absorption of incident light and thus can be measured using 
a UV-Vis absorption spectrometer. Therefore, modification of SPR by varying the size and 
shape of AuNP is useful in the synthesis of functionalised AuNPs with specific optical 
properties for different biomedical applications (Amendola et al., 2017).  
The SPR also strongly affects the aspect ratio of nanoparticles.  Aspect ratio is defined as 
the length of the major axis divided by the width of the minor axis, therefore nanoparticles 
that are spherical have an aspect ratio of 1 (Murphy & Jana, 2002). When the shape of AuNP 
changes from spheres to rod, the SPR produces a strong band in the near-infrared region, 
which corresponds to the amplitude of the oscillating electrons (Huang & El-Sayed, 2010). 
This band (which is usually in the visible region), shifts largely from visible region to near-
infrared region and results in increased aspect ratio as well as colour change as observed in 
lower panel of      
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Figure 5 (Huang & El-Sayed, 2010). An example of aspect ratio effect is a change in shape: 
Gold nanorods can be formed by asymmetric growth of spherical AuNPs in the presence of 
shape-forming surfactants, weak reducing agents and catalysts (Huang & El-Sayed, 2010; 
Ward et al., 2014).  
     
 
Figure 5:  Images of aqueous solutions of gold nanoparticles (AuNP) 
 Nanospheres (upper panels) and gold nanorods (lower panels). The AuNP and their corresponding 
transmission electron microscopy images are shown with a scale bar representing 100 nm. Sphere 
(upper panel a-e) showed a less change in colour with increasing size compared to the rods (lower 
panel f-k).The difference in colour is because of plasmon band, which has greater effect on rods 
compared to spheres. Image adapted from (Murphy et al., 2008).  
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The most common method for the synthesis of monodisperse spherical AuNP was pioneered 
by Turkevich et al. (1951) and later refined by Frens (1973). It involves the chemical 
reduction of gold salts such as hydrogen tetrachloraurate (HAuCl4) in aqueous, organic or 
mixed solvent systems. Aggregation tends to occur because of the high reactiveness of gold 
surface, which results in collision of colloidal particles with each other due to Brownian 
motion, gravity and similar forces present in the colloidal suspension (Hotze et al., 2010). 
The main reason for aggregation of particles in colloidal suspension is van der Waals forces 
that attracts particles in close proximity and causes destabilization (Zhou et al., 2007). It is 
essential for AuNP to be stably dispersed in biological fluid for most of its biomedical 
applications. To avoid the issue of aggregation; AuNP are regularly reduced in the presence 
of stabilisers, which bind to its surface and prevents aggregation via cross-linking and charge 
properties (Castro & Kumar, 2013). The stabiliser aims to introduce repulsive forces 







Figure 6: Schematic representation of electrostatic and steric stabilization in 
metal nanoparticles.  
Electrostatic stabilization of positively charged nanoparticles produced double layer of 
negative charge around it, preventing aggregation between the particles in solution. While, 
in steric stabilization polymer forms a coating around metal nanoparticles. Image adapted 
from (Gual et al., 2010). 
 
Steric stabilization Electrostatic stabilization 
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The major methods of stabilization of colloidal AuNP are electrostatic stabilization and 
steric stabilization (Babu & Dhamodharan, 2009; Lin et al., 2004). Electrostatic stabilization 
is a kinetic mechanism based on the generation of an electrical double layer of ions around 
the particles. The double layer causes repulsion between particles by counterbalancing the 
van der Waals force by repulsive Coulomb force that acts between the charged colloidal 
particles and provides stability (Brown et al., 2016; Kraynov & Müller, 2011; Polte, 2015). 
Steric stabilization is a thermodynamic mechanism based on the coordination of sterically 
bulky organic macromolecules such as polymers and surfactants. They act as a protective 
shield on metallic surface of particle preventing attractive force between particles (Polte, 
2015; Zhou et al., 2009). Because steric stabilization is a thermodynamic stabilization, 
particles are re-dispersible when slightly aggregated unlike particles with electrostatic 
stabilization (Babu & Dhamodharan, 2009; Chow & Zukoski, 1994). Citrate stabilization is 
a form of electrostatic stabilization as it provides a repulsive force; this method of 
stabilization was employed during the synthesis of AuNP used in this research for cellular 
studies.  
1.1.1. Cellular Uptake of Gold Nanoparticles.  
Cellular uptake of AuNPs occurs via several pathways that are dependent on particle 
physiochemical properties such as size, shape and surface coatings (Chithrani et al., 2006; 
Kunzmann et al., 2011; Nativo et al., 2008). Cellular uptake of AuNPs into cells is necessary 
in exerting specific function/target in the cells; therefore, it is necessary to understand the 
mechanism of cellular uptake.  
For cellular uptake to occur, particles must cross the barrier of the plasma membrane, which 
is selectively permeable to control the entry and exist of molecules in and out of the cell.  
Smaller molecules such as amino acids, sugars and ions move across the membrane by 
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diffusion, osmosis and mediated-transport system; active transport and facilitated diffusion 
(Conner & Schmid, 2003). While molecules too large to pass through the cell membrane like 
AuNP move across the membrane by endocytosis (Levy et al., 2010).  
Endocytosis is a form of active transport where uptake occurs by cells engulfing the molecule 
aimed at internalization. Endocytosis is broadly classified into phagocytosis (cell eating) and 







Figure 7:  Multiple portals of entry into the mammalian cell. 
The endocytic pathway differs with regard to the size of the endocytic vesicle, the nature of the cargo 
and the mechanism of vesicle formation. Pinocytosis is the general mode of uptake in non-phagocytic 
cell. Image adapted from (Conner & Schmid, 2003)  
Phagocytosis involves cells engulfing large particles (> 0.5 µm) such as bacteria or cell 
debris and is restricted to specialised phagocytic cells such as cells involved in immune 
response for example: macrophages (Stow & Condon, 2016). Pinocytosis involves the 
uptake of fluids and solutes and is the most common form of uptake in eukaryotes (Conner 
& Schmid, 2003). The two major types of pinocytosis are macropinocytosis and receptor-
mediated endocytosis (RME) that is further divided into clathrin, and caveolin mediated 
endocytosis (Gao et al., 2005). Macropinocytosis is highly dependent on actin cytoskeleton 

















               Pinocytosis 
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protrudes from the plasma membrane and re-joins the plasma membrane after engulfing 
solutes (Doherty & McMahon, 2009). Clathrin-mediated endocytosis is the most studied and 
best understood form of receptor-mediated endocytosis. It occurs by an inward budding of 
the plasma membrane and formation of clathrin-coated vesicles (Johannes et al., 2015). 
Caveolin mediated endocytosis involves the formation of a flask shaped invagination 
composed of lipids rafts from the plasma membrane and their mechanism is poorly 
understood (Andrews et al., 2014; Kirkham & Parton, 2005).  Clathrin and Caveolin- 
independent endocytosis are methods of cellular uptake that do not fall into aforementioned 
categories. They do not involve the use of actin filaments, clathrin coated pits or caveolae 
flask (Damm et al., 2005; Mayor & Pagano, 2007). They are the least understood mode of 
cellular uptake. 
The exact mechanism by which AuNPs enters cells is still the subject of much debate; 
typically, delivery of ENPs into cells involves attachment to receptor on the cell surface 
plasma membrane, followed by internalization due to endocytosis (Treuel et al., 2013). 
Various researchers have confirmed via TEM images, that the internalization of AuNPs in 
common cell line models such as HeLa, A549, Caco-2 cells, HEK 293 occurs by endocytosis 
(Giljohann et al., 2010; Oh & Park, 2014; Park et al., 2009; Tlotleng et al., 2016). According 
to Chithrani et al. (2006), they hypothesize and demonstrated RME to be the major 
mechanism of cellular uptake of spherical shaped citrate capped AuNP by using  transferrin-
coated AuNP. Similar study have shown using AuNP of ≤ 100 nm to be internalised by RME 
(Chithrani & Chan, 2007; Nativo et al., 2008; Shukla et al., 2005).   
In RME, the receptor recycles back to the plasma membrane surface after cellular 
internalization of ENPs (Chithrani et al., 2006; Xu et al., 2013). Cells have a maximum 
receptor density (the number of receptors per cell surface area on the membrane) therefore, 
the availability of receptors affects the cellular uptake of particle in terms of quantity 
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(Chithrani et al., 2006). Cellular uptake of ENPs leads to the localisation within vesicles 
usually endosomes (Kou et al., 2013; Yameen et al., 2014). The endosomes are formed from 
the invagination of the membrane after the uptake of particles and undergoes fusion with 
other organelles in the cells usually the lysosome (Panariti et al., 2012). The fusion of the 
endosome and the acidic lysosome can result in degradation of nanoparticles by lysosomal 
enzymes (Sabella et al., 2014; Stern et al., 2012).  
Efficient endocytosis of AuNP is dependent on physiochemical properties such as particle 
shape, size and surface properties (Alkilany & Murphy, 2010; Chithrani, 2011; Kou et al., 
2013; Levy et al., 2010; Wang et al., 2015). AuNP can be synthesised to various shapes: 
spherical, rod, star or triangular plate and the shape affects the way is taken up by the cells. 
Chithrani et al. (2006) demonstrated that spherical AuNPs were more rapidly internalised in 
cells by RME (clathrin-mediated endocytosis) compared to gold nanorods. HeLa cells were 
treated with spherical AuNPs with diameter of 14, 30, 50, 74 and 100 nm and gold nanorods 
with length by width of 40 x14 nm and 74 x14 nm were for 6 hours. Their result showed 
cellular uptake measured quantitatively by ICP-ACES to be greater in spherical AuNPs of 
74 and 14 nm diameter compared to rod-shaped AuNP of 74x14 nm. They attributed the 
differences in uptake to the curvature of the different-shaped nanoparticles and the surfactant 
used during synthesis. They propose that the rod-shaped AuNPs have more contact area to 
interact with the cell membrane receptors than the spherical, thereby reducing the number of 
available receptor sites for binding. They also propose that the surfactant used 
cetytrimethyammonium bromide (CTAB) during synthesis is adsorbed onto the rod-shaped 
nanoparticles and if not properly purified can interfere with the serum protein that normally 
binds to AuNPs and aids cellular uptake (Chithrani et al., 2006).  
The cell plasma membrane has a strong negative charge because of phosphate groups 
attached to the lipid bilayer. Therefore, the charge of AuNP also affects its interaction with 
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plasma membrane. Studies have shown that positively charged AuNPs are more readily 
internalised (Gong et al., 2015), this can be attributed to differences in charge of particle and 
plasma membrane thereby causing an attraction observed as cellular uptake. In vitro, when 
particles are dispersed in cell culture media, the media can influence their surface charge, 
which then affects their cellular uptake (Strojan et al., 2017).  
Cell culture media is a complex aqueous mixture of electrolytes, serum proteins, nutrients, 
antibiotics and metabolites and the various components can interact with nanoparticles and 
have an effect on cellular uptake. Serum proteins present in media are capable of being 
adsorbed onto the surface of nanoparticles and form a protein corona, which is a 
nanoparticle-protein complex (Fleischer & Payne, 2014; Piella et al., 2017). Protein corona 
formation is dependent on various factors such as size, surface coating of nanoparticles and 
composition of the media (Rahman et al., 2013; Strojan et al., 2017). The composition of 
the media used for the dilution of ENPs is very important in the protein corona formation 
and ultimately the uptake. This was demonstrated by Maiorano et al. (2010) using AuNPs 
in two commonly used cell culture media; Dulbecco Modified Eagle’s medium (DMEM) 
and Roswell Park Memorial Institute medium (RPMI) both supplemented with 10% fetal 
bovine serum (FBS) and mixed with different sizes of spherical citrate-capped AuNPs in 
two cell lines HeLa and U937 (human lymphoblast cell line). They observed that protein-
gold nanoparticles formed in RPMI were abundantly internalised in cells compared to 
DMEM evident from their absorption spectra of AuNPs in different media. However, 
DMEM formed large time-dependent protein corona compared to RPMI. They attributed the 
differences found in the cellular uptake of AuNPs to differences in protein corona formation 
to be a co-operative mechanism of different parameters such as protein-AuNP interaction, 
protein-protein interaction, protein-media components and AuNPs-media components 
(Maiorano et al., 2010). There is a lot to understand about protein corona because its dynamic 
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and changes with time and environment (Hamad-Schifferli, 2015). It is worth noting that 
AuNP is plausible of getting a new biological identity when mixed with media, which the 
cells recognises during cellular uptake. In addition, there is a tendency of nanoparticles to 
aggregate in the media (Moore et al., 2015) which in turn influences their cellular uptake 
and cellular fate.  
The effect of AuNP aggregation on cellular uptake and toxicity was demonstrated by 
Albanese and Chan (2011) using transferrin-coated AuNP aggregates of different sizes in 
A549, HeLa and MDA-MB 435 cell line. Interestingly, their result showed no difference in 
toxicity response between aggregated and single particles but the uptake patterns between 
the aggregated and single particles were different. Aggregated particles showed an increased 
uptake in Hela and A549 cells compared to single particle. This study shows the importance 
of considering aggregation when studying the uptake of particle because; uptake influences 
intracellular trafficking and understanding the cellular uptake mechanism helps determine 
subsequent molecular response of the cell. 
1.2.2. Intracellular Localisation and Cellular Fate of Gold Nanoparticles.  
The localisation of AuNP within the cell is important for understanding their mechanism of 
interaction with sub-cellular components and hence their potential toxicity. Most studies on 
localisation involve fluorescent-labelled nanoparticles and the use of confocal microscopy. 
The limited resolution of confocal microscopy makes it hard to determine the exact 
position/location of the particle in the cell (Iversen et al., 2011; Stefancikova et al., 2014). 
To resolve the issue, Transmission electron microscopy (TEM) technique is widely used as 
a supplement for the study of cellular fate of nanoparticles in addition to characterization of 
shape and size of nanoparticles (Weir et al., 2008). TEM has a resolution of about 0.2 nm 
(Chapman et al., 2012) and the electron density of gold atoms gives it a high contrast upon 
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biology matrix enabling a better study of sub cellular localisation of AuNPs (Chen et al., 
2013). 
As mentioned earlier, the proposed mechanism of cellular uptake of AuNP is via 
endocytosis, which involves the formation of vesicles. These formed vesicles traffic their 
content to early endosomes first irrespective of the type of endocytosis (Kou et al., 2013; 
Panariti et al., 2012; Xu et al., 2013). The early endosomes, considered to be the main sorting 
station can then transfer it content to the late endosomes and lysosomes via endocytic 
trafficking (Liu et al., 2013). During endocytic trafficking, there is a decrease in pH in 
vesicles from the endosomes (6.5) to the lysosomes (4.5) that is the organelles become 
acidified as shown in Figure 8.  
      
Figure 8: Endosomal trafficking. 
Formed vesicles from the plasma membrane, transports it content to early/sorting endosomes, 
where sorting takes places. AUNPs are transported to either the recycling membrane, Golgi or 
late endosome/multivesicular bodies and finally to the lysosome for degradation. Image taken 
from (Elkin et al., 2016). 
 
Therefore, it is expected to observe particles in the early endosome, late endosome, multi-
vesicular bodies (MVB), golgi network and lysosome and this was proven by several 
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studies, showing AuNP within these organelles (Kim et al., 2015; Levy et al., 2010; Ma et 
al., 2011; Wang & Petersen, 2013).  
However, AuNP have also being reported to be localised in other organelles not associated 
with endosomal trafficking, organelles such as mitochondria (Karatas et al., 2009; Kodiha 
et al., 2015) or even free in the cytosol (Verma et al., 2008). Gu et al. (2009) showed AuNP 
modified with poly (ethylene glycol) (PEG) and 3-mercaptopropionic acid (MPA) studied 
in HeLa cells penetrated into the nucleus of mammalian cells after a 24-hour treatment. 
This is a good evidence of localisation in organelles not involved in endosomal trafficking, 
as well as a possibility of nuclear localisation, thereby, increasing the potential of AuNP 
for nuclear targeted drug delivery.  
In endosomal trafficking, the lysosome is often viewed as the last target for internalised 
particles (Yameen et al., 2014). This is because; the lysosome is the digesting or recycling 
components of the cell machinery (Shukla et al., 2005; Yameen et al., 2014). Trafficked 
AuNPs in the late endosomes vesicles fuses with the primary lysosomes of the cells 
(originates from the golgi) to form secondary lysosomes (Huotari & Helenius, 2011; Taylor 
et al., 2016). However, the cellular fate of AuNPs in the lysosome is inconclusive. Most 
studies reports AuNPs remains in membrane bounded vesicles (Kim et al., 2015) arranged 
in a perinuclear fashion (Shukla et al., 2005) with a possibility of exocytosis of AuNPs 
from the cell (Chithrani et al., 2006). A suggested rationale of AuNP persistence in the 
lysosome could be that, the digestive enzymes of the lysosomes is not designed to digest 
metals but are capable of forming complex with the metals (Pernodet et al., 2006).  
In summary, AuNP generally has a nonspecific subcellular localisation, as it moves 
between organelles but its most often concentrated in endosome/lysosomes (Dykman & 
Khlebtsov, 2012; Kodiha et al., 2015; Levy et al., 2010). However, with specific targeting 
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like attaching peptides or antibodies onto AuNP surface, this helps to achieve targeted 
subcellular organelle localisation. 
One of such targeted subcellular organelles localisation in vitro was to the nucleus of 
HepG2 cells using peptide-modified AuNPs complex, the modification was with  nuclear 
localisation signals and adenovirus receptor-mediated endocytosis peptide attached to the 
AuNPs as two separate pieces by Tkachenko et al. (2003). Their differential interference 
contrast (DIC) imaging result showed nuclear localisation and the ability of functionalizing 
AuNPs for targeted subcellular localisation. Worth noting from their experiment was the 
mix of two different peptide to achieve nuclear localisation, they reported NLS peptide 
modified AuNPs alone showed no internalisation and adenovirus receptor-mediated 
endocytosis peptide modified AuNPs does not achieve nuclear localisation. It is clear that 
physio-chemical properties of AuNP affect the uptake, which then affects its subcellular 
localisation. Therefore, uptake mechanisms evading endocytic trafficking would decrease 
its endosome/lysosome concentrations and increase its intracellular concentration in other 
organelles especially the nucleus. Hence, the emphasises on understanding the mechanism 
of uptake and trafficking of AuNPs to determine subcellular localisation and cellular fate 
would be beneficial for its biomedical applications.  
Although the ultimate cellular fate of AuNPs is not clear, there are two likely possibilities: 
passing on AuNP to daughter cell during cell division (Mironava et al., 2010) or exocytosis 
(Oh & Park, 2014), with more research focus on the later. Chithrani and Chan (2007) 
demonstrated the exocytosis of transferrin coated AuNPs (14 nm and 74 nm) following 
cellular internalization by clathrin-mediated endocytosis. Smaller AuNPs (14 nm) 
underwent exocytosis two times faster compared to larger AuNPs (74 nm) implying that 
exocytosis is size dependent. They concluded that although exocytosis was size dependent, 
size alone does not influence exocytosis other parameters should be considered as well. 
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Interestingly, they also observed exocytosis occurred when vesicles with entrapped AuNPs 
moves towards the cellular membrane, fuses with it and then releases its content (entrapped 
AuNPs) to the external cellular environment. Using the study above as a case study of 
cellular localisation with a bit of exocytosis occurring, it is assumed that most of the particle 
are still internalised, with only a few undergoing exocytosis. Therefore, it is necessary to 
study the toxic effects of the internalised AuNPs to the cells.  
1.2.3. Cytotoxicity of Gold Nanoparticles. 
The cellular internalization of AuNPs leads to potential interactions with cellular organelles 
such as mitochondria, golgi, nucleus or lysosomes. These interactions can produce toxic 
effects such as organelle or DNA damage, oxidative stress, apoptosis, mutagenesis and 
dysregulation of protein (Aillon et al., 2009; Manke et al., 2013; Nel et al., 2006; Pan et al., 
2009; Rim et al., 2013; Unfried et al., 2007). Although bulk gold has been found to be 
generally safe and inert, AuNPs are regarded to have some toxic potential (Arvizo et al., 
2010). The toxicity of AuNPs has been investigated at cellular levels focusing on the various 
properties such as surface characteristic, concentrations, size, shape, and as well as 
composition of exposure medium (Boisselier & Astruc, 2009; Murphy et al., 2008; Wang et 
al., 2015). Contradictory results about the cytotoxicity have been reported and further 
research is therefore required.  
Using 14 nm citrate-capped AuNP at various concentrations (0.2, 0.4, 0.6, 0.8 mg/mL), 
Pernodet et al. (2006) investigated the effect of concentration and exposure time (2, 4 and 6 
days) on human dermal fibroblast. Their results showed that greatest accumulation of AuNPs 
in the cell occurred at the highest concentration and that cellular uptake was concentration 
and time dependent. AuNPs were observed to accumulate in vacuoles in cells; surprisingly 
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they did not identify the vacuoles. Also, observed was damage to actin filaments compared 
to their control evident from their fluorescence imaging.  
This damage affected the motility, proliferative and adhesive abilities of cells. After 6 days, 
they observed the largest inhibition on the proliferation of cells suggesting that 14 nm citrate 
capped AuNPs entry to cell is not immediately detrimental to cell function but rather the 
formation of an unusual large number of vacuoles that triggers a series of secondary events 
such as cell growth and protein synthesis. This study showed the long-term effect of AuNPs 
exposure to cells, which most studies have not shown because of their short exposure time 
of 24 hours or less. A similar study by Mironava et al. (2010) using 13 nm and 45 nm AuNPs 
on human dermal fibroblast also showed similar result of decreased proliferation, 
cytoskeleton disruption and induction of apoptosis. They attributed their result to the number 
of vacuoles rather than the concentration of the particle within the cells. Wei et al. (2007) 
study the effect of 25 ± 3.5 nm spherical AuNPs on human hepatoma HepG2 cells a cancer 
cell line and their result showed AuNP had a low effect on proliferation but disrupted cell 
adhesion. It should be noted that although these experiment used similar AuNPs, which were 
spherical citrate AuNPs on different cell lines, the outcomes were different. Therefore, the 
toxicity observed on AuNPs exposure cannot be generalised without considering other 
parameters discussed below as well as examining toxicity of AuNPs on a case-case basis.  
The charge and surface coating of AuNPs can influence its cytotoxicity potential (Zhang et 
al., 2012). Interaction of ENPs generally with the plasma membrane also influences it 
toxicity (Wang et al., 2015). The plasma membrane carries a negative charge, therefore 
AuNP coated with cationic ligand such as cetytrimethyammonium bromide (CTAB) disrupts 
the plasma membrane which increases cytotoxicity compared to AuNP conjugated with 
biotin, cysteine, citrate, glucose and polyethylene glycol (PEG) (Alkilany & Murphy, 2010; 
Boisselier & Astruc, 2009; Murphy et al., 2008; Verma & Stellacci, 2010). Goodman et al. 
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(2004) designed spherical AuNPs, which were either cationic or anionic and studied their 
toxicity in vitro. They observed that although both particles interacted with cells in a passive 
process, cationic AuNPs interacted strongly with the negatively charged plasma membrane 
compared to the anionic AuNPs. This strong electrostatic attraction of cationic AuNP with 
the plasma membrane caused a membrane disruption capable of inducing a variety of further 
interactions, which could be linked to observed toxicity of cationic AuNPs. In addition, the 
observed toxicity was found to be concentration dependent. An identical research by Connor 
et al. (2005) demonstrated the effect of surface modification with several ligands; citrate, 
biotin and CTAB. Citrate and biotin modified AuNP were non-toxic up to concentration of 
250 µM whereas CTAB coated AuNP where already toxic at 0.05 µM, interestingly when 
CTAB coated AuNP were centrifuged and washed to remove unbound CTAB, the particles 
lost their toxic properties. CTAB is a commonly used cationic surfactant to stabilise AuNP 
and CTAB alone has been found to be quite toxic to the cells at sub-micromolar dose 
(Alkilany et al., 2009). Clearly surface modification impacts on cytotoxicity of AuNP and 
the toxicity observed could originate from either the AuNP, its surface coating or 
functionalised AuNP (Connor et al., 2005). Table 1 shows a summary of in vitro AuNPs 




Table 1: Summary of in vitro gold nanoparticle toxicity results based on surface coating 
Selected references were chosen based on experiment that focused on cytotoxicity of surface 




Cell Line  AuNP characteristics  
(size, shape and surface 
coating) 
Toxicity Conclusion  Ref  
COS-1, Red 
blood cells and E. 
coli 
2 nm Sphere. Coating: 
Quaternary ammonium, 
carboxylic acid 
Cationic nanoparticles found to 
be toxic and anionic not toxic.  
(Goodman et al., 
2004) 
K562  4, 12 and 18 nm Sphere. 
Coating:CTAB, citrate, cysteine, 
glucose, biotin 
All nanoparticles were not 
toxic, although the surface 
coating may be toxic 
(Connor et al., 
2005) 
HeLa 65 × 11 nm Rods. Coating: 
CTAB, PEG 
Replacing CTAB with PEG on 
the surface of nanorods reduced 
the toxicity 




13.1 nm Sphere. Coating: Citrate  Nanoparticles decreased cell 
proliferation rate, adhesion, and 
motility 
(Pernodet et al., 
2006) 
Hep2G, 
BHK21and  A549 
33 nm Spheres. Coating: CTAB 
and citrate 
Non-toxic to Hep2G and 
BHK21 but to A549 cell line 
(Patra et al., 
2007) 
HeLa 18 nm Sphere. Coating: Citrate Non- toxic and no change in 
gene-expression patterns 
(Khan et al., 
2007) 
HeLa 3.7 nm Sphere. Coating: PEG Nanoparticles entered nucleus 
and did not induce toxicity 




10–80 nm sphere, rod and urchin. 
Coating: PEG and CTAB 
Autophagy and  phagocytosis (Hutter et al., 
2010) 
HaCaT  1.5 nm Sphere. Coating:  
Postively charged 
(trimethylammoniumethanethiol)




Cell morphology was disrupted 
by all three NPs in a dose-
dependent manner; charged 
NPs induced cell death through 
apoptosis while  neutral NPs via 
necrosis 




55.6 × 13.3 nm Rod. Coating: 
serum protein-coated 
Selective lysosomal membranes 
and actin damage 
(Wang et al., 
2011) 
A549, 16HBE 55 rod Coating: CTAB Oxidative stress, mitochondria 
damage 
(Zhang et al., 
2013) 
Vero, NIH3T3 
and MRC-5 cells.  
nano-rod structure with an 
average length of 10–40 nm 
Decreased cell growth 
associated with apoptosis 
induction in Vero cells and 
autophagy in NIH3T3 cells. 
cDNA microarray analyses of  
MRC-5 cells showed 
involvement of DNA damage 
and repair responses, cell-cycle 
regulation, and oxidative stress.  
(Chueh et al., 
2014) 
A549 cells 25 × 52 nm rod, Coating Citrate.  Decreased cell viability and 
increases ROS production  
(Tang et al., 
2015) 
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From Table 1, AuNP mediated toxicity are often associated with oxidative stress, 
mitochondria damage, apoptosis, necrosis, autophagy, genotoxicity and inhibition of cell 
division and proliferation. The most common and studied mechanism involved in AuNP 
toxicity is the production of reactive oxygen species (ROS) (Fard et al., 2015; Oo et al., 
2012; Schaeublin et al., 2011). ROS are highly reactive oxygen radical formed upon the 
incomplete reduction of molecular oxygen (Nordberg & Arner, 2001).  
ROS are generated within the cells by normal cellular activities such as mitochondria 
respiration and are involved in cell signalling and homeostasis (Bolisetty & Jaimes, 2013). 
In addition, exogenous generation of ROS could be by pollutant, ENPs, chemicals and 
ionizing radiation (Minai et al., 2013; Valko et al., 2006). When the production of ROS is 
not counterbalanced by antioxidant production, this leads to oxidative stress (Manke et al., 
2013). Oxidative stress results in mitochondria membrane damage thereby disrupting 
electron transport chain and other downstream effects such as DNA damage, apoptosis, lipid 
peroxidation and activation of signalling networks linked with cell cycle (Ott et al., 2007). 
These changes have been observed in cells exposed to AuNPs (Alkilany & Murphy, 2010; 
Kovacic & Somanathan, 2013; Madl et al., 2014; Pan et al., 2009), therefore the emphasises 
on AuNP-mediated ROS generation. As mentioned above, ROS generation and its effects 
have been reported on cell lines exposed to AuNPs the exact underlying cellular mechanism 
is still elusive. A proposed mechanism of intracellular ROS generation is the direct or 
indirect interaction of AuNPs with the mitochondria because mitochondria is the main 
source of ROS (Dayem et al., 2017). Interaction with the mitochondria leads to a cascade of 
events plausible of inducing oxidative stress and cytotoxicity as shown in Figure 9.  
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Figure 9: Possible ROS mediated mechanism of toxicity.  
Nanoparticles are capable of interacting with mitochondria, disrupting it function and leading to production 
of ROS. ROS production can cause a cascade of events such as nuclear damage, lipid peroxidation and 
oxidative stress. Oxidative stress causes a reduction in antioxidant, release of cytokines, protein denaturation. 
All this results in cytotoxicity. Images adapted from  (Sanvicens & Marco, 2008) 
 
Nanoparticles have also been proposed to interact with enzymes involved in maintaining 
cellular redox potential and activation of intracellular signalling pathways that induces ROS 
generation (Auffan et al., 2009). The activated pathway is the stress-dependent signalling 
pathway such as mitogen-activated protein kinase (MAPK) or IκB kinase, which ultimately 
alters the gene expression of the antioxidant response element by activating transcription 
factors, such as AP-1, NF-kB, or Nrf2, and finally leading to ROS generation. (Feng et al., 
2015; Soenen et al., 2011). In vitro studies have demonstrated an increase in oxidative stress 
and lipid peroxidation by western blotting of autophagic protein (LC3) and malondialdehyde 
(a by-product of lipid peroxidation) (Li et al., 2010). In addition, the measurement of 
glutathione (GSH) an antioxidant that deactivates intracellular ROS has been demonstrated 
to diminish on exposure of AuNPs (Zhang et al., 2013). All these evidences links the 
observed cytotoxicity on exposure to AuNPs to the generation of ROS which can arise from 
either the gold core, its surface coating or the functionalised AuNP itself.  
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1.3. Functionalization of Gold Nanoparticles with Metal Complex. 
Functionalization is the process of adding new functions or modifying the characteristics of 
a material by changing it surface chemistry. Functionalization of ENPs aims to give it a 
tailored property or function. Functionalization of ENPs surface can be after the synthesis of 
the particle by the addition of thiols, disulphides, amines, nitriles and biomolecule group 
which bind to the surface of the particle or enable secondary binding of other functional 
groups/probe (Roux et al., 2005; Woehrle & Hutchison, 2005; Zhou et al., 2009). 
Functionalization of ENPs can be direct or post-functionalization. In direct approach, the 
functional ligand is a bi-functional compound, with one of the functional group attaching to 
ENP surface while the other functional group contains the required active functionality i.e. 
the desired properties to be added to the ENP (Subbiah et al., 2010). In post-functionalization 
approach, a binding chelating group is used to produce a coupling site, where the final 
functional group is attached (Subbiah et al., 2010).  
AuNP can be easily functionalised because of its large surface to mass ratio that acts as 
scaffold to enable attachment of multiple probes onto its surface (Rogers et al., 2014). The 
attachment of probes onto AuNP surface modifies the fluorescence signal usually generated 
from AuNP alone, therefore functionalised AuNP acts as a nanoprobe with unique optical 
properties, large Stokes shift and high photo stability (Osborne & Pikramenou, 2015). The 
type of probes usually attached to AuNP includes; metal complex, ions or bio-molecules 
(Lewis & Pikramenou, 2014; Lo et al., 2012). For the purpose of this thesis, only metal 
complex coating would be discussed. 
Metal complex consist of a central metal surrounded by molecules or ions known as ligands 
and the metal complex acts as a Lewis base (electron donor). The biomedical application of 
metal complex is usually as a chemotherapeutic agent such as cisplatin or as a diagnostic 
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tool for medical imaging such as Magnetic resonance imaging (MRI), Positron emission 
tomography (PET), Single-photon emission computed tomography (SPECT) and 
fluorescence cell imaging (Arrowsmith et al., 2012; Fernandez-Moreira et al., 2010; Tanaka 
& Fukase, 2008).  
The most biologically used metal complexes for imaging are transition metals and 
lanthanides because of their high photo-stability compared to organic dyes (Lewis & 
Pikramenou, 2014).Transition metals are elements with partially filled d orbital while 
lanthanides are f block elements of the periodic table. Both transition metals and lanthanides 
have been reported to be functionalised onto AuNPs surface for imaging purposes (Comby 
et al., 2014; Zhang et al., 2016). Transition-metal complex  is prepared in fewer steps, which 
are easily modifiable and also their variable oxidation state can coordinate ligands to form 
different geometrics as well as  participate in various biological redox reactions (Ma et al., 
2013a). Transition-metal complex produces strong and sufficiently long-lived 
phosphorescence emission that allows the imaging of biological events (Demas & DeGraff, 
2001; Ma et al., 2013b). Hence, their ability to modify the fluorescence nature of AuNPs 
and making functionalised AuNPs attractive as a nanoprobe for bio-imaging. Labelling of 
AuNPs with transition metal complexes assigns it, unique optical properties of luminescence 
(Lewis & Pikramenou, 2014). These properties includes long emission half-life, photo-
stability, and emission spectra within the visible region (Rogers et al., 2014). These 
properties confer them with the ability for application in time-resolved emission imaging 
microscopy (TREM), fluorescence lifetime imaging microscopy (FLIM) and continuous 
monitoring of biological events (Botchway et al., 2008; Svensson et al., 2011).  
Transition metal complexes of ruthenium (II), iridum (III) have been reported to coat the 
surface of AuNPs (Adams et al., 2014; Elmes et al., 2011; Glomm et al., 2005; Huang & 
Murray, 2002; Jebb et al., 2007; Rogers et al., 2014) and has been used for cellular studies 
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(Elmes et al., 2011; Rogers et al., 2014). Only a few studies have functionalised AuNP with 
ruthenium metal complex for cellular studies, however the most used ruthenium complex 
ruthenium trisbipyridine [Ru(bpy)3]2+ photophysical properties is well documented (Juris et 
al., 1988; McCusker, 2003). Our lab has successfully coated ruthenium complex onto AuNP 
surface and used it for cellular studies (Rogers et al., 2014). Luminescence imaging of this 
ruthenium functionalised AuNP by confocal microscopy was possible and also observed was 
the stability of the ruthenium complex on AuNP even after 24 hours incubation (Rogers et 
al., 2014). The preliminary result gotten in our lab that showed the potential of these particles 
to be used as nanoprobe without been toxic, led to the recent synthesis of a more luminescent 
ruthenium functionalised AuNP published in Osborne and Pikramenou (2015). Although 
previous ruthenium functionalised AuNPs showed cellular internalization and no 
cytotoxicity in A549 cells, the mechanism of cellular uptake, and fate was not studied. Upon 
synthesizing a more luminescent ruthenium functionalised AuNP (Osborne & Pikramenou, 
2015) which has a potential as a nanoprobe, this current research was carried out to fill the 
knowledge gaps about the mechanism of uptake, cellular fate and plausible toxicity of this 
functionalised AuNP in A549 cells. A549 cells was chosen based on preliminary data on 
cellular uptake of nanoparticle obtained in our lab. A549 cells are human cell line gotten 
from lung tissue, epithelial in nature and grow as a monolayer adherent cell line (Foster et 
al., 1998)They are mostly used for enzymatic studies because it is a very transfection host, 
cell proliferation studies and the mechanism involved and recently in the study of 




1.4. Hypothesis and Objectives.  
The therapeutic and diagnostic potential of AuNPs generally has been established from the 
review above, however various challenges limits the clinical translation of AuNP. The lack 
of understanding of the mechanism of cellular uptake, localisation and possible toxicity that 
needs further careful evaluation both in vitro and in vivo. Various AuNPs can be synthesised 
with different characteristic for different purposes, therefore the study of AuNP should be 
treated on a unique case-by-case basis.  
This research is aimed at critically understanding the mechanism of uptake of functionalised 
AuNP coated with ruthenium bipyridine SS, (a luminescent transition metal complex), as 
toxic effects, sub-cellular localisation and cellular fate are dependent on uptake mechanism. 
The functionalized AuNP would be referred to as RuS12·AuNP20 throughout this thesis. 
Human lung adenocarcinoma epithelial cell line (A549 cells) were used for this study 
because of preliminary data on the uptake of ruthenium coated gold nanoparticle in our lab.  
We hypothesized based on preliminary data and literature review that internalised 
RuS12·AuNP20 in A549 do not cause toxicity up to 72 hours but induces cellular stress due 




1. Investigate the mechanism of cellular uptake of RuS12·AuNP20 in A549cells and 
quantify internalised RuS12·AuNP20.  
2. Investigate the sub-cellular localisation and cellular fate of internalised 
RuS12·AuNP20 by different imaging modalities. Molecular probes as well as transiently 
transfected cells expressing GFP-tagged organelle marker would be used as model for 
investigating sub-cellular localisation.  
3. Investigate the ultimate cellular fate of RuS12·AuNP20 in A549 cells by trafficking 
particles over a 72 hours period. 
4. Investigate the toxic potential of RuS12·AuNP20 in A549 cells by cytotoxicity testing 





Materials and Methods 
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Chemicals and Consumables.  
Unless otherwise stated, all chemicals and consumables were purchased from Sigma-
Aldrich-UK and were of the highest quality available.  
2.1. Nanoparticle Synthesis.  
2.1.1 RuS12·AuNP20 Synthesis. 
The colloids (AuNP) were prepared first and coated with Zonyl® FSA fluorosurfactant 
followed by final coating with transition metal complex; ruthenium-bipyridine-SS (RuS12), 
which was prepared, characterised as described previously and published by Osborne and 
Pikramenou (2015). Details of ruthenium complex synthesizes is provided in appendix 2A. 
I acknowledge Shani Osbourne for providing all the ruthenium complexes used for this 
research. Coating with the fluorosurfactant was to enable high loading of ruthenium-
bipyridine-SS onto AuNP surface as well as stabilizing the nanoparticle. Schematic of the 
synthesis is shown in Error! Reference source not found. 
2.1.1.1. AuNP Colloid Preparation. 
Synthesis of Au colloid was performed according to procedure described by Schulz et al. 
(2014). All glassware used in this preparation were initially washed with freshly prepared 
aqua regia (3:1 HCl/HNO3), then distilled water and followed by drying in an oven. The 
preparation was as followed: In a 250 ml round bottom flask attached to a condenser on a 
heater plate, the following compounds (60.0 mg, 0.2 mmol of trisodium citrate; 13.3 mg, 0.7 
mmol critic acid and 1.0 mg, 0.004 mmol ethylenediaminetetraacetic acid (EDTA)) were 
dissolved in 100 ml of deionised water, heated to 1500C and refluxed for 15 minutes. 8.0 
mg, 0.022 mmol of HAuCl4.3H2O (Alfa Aesar) was dissolved in 25 ml deionised water and 
gently heated in a 1200C oven for about 10 minutes, and then rapidly added to the content of 
round bottom flask and refluxed for 10 minutes with vigorous stirring. A change in colour 
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from pale yellow to wine red was observed indicating the reduction of gold salts and 
formation of nanoparticles. Heating was removed but stirring was continued for an additional 
30 minutes to enable slow cooling to room temperature.  
The resulting solution of colloids (1.6 nM) was characterised by determining the surface 
plasmon resonance (SPR) by collecting UV-VIS spectra using a 1 cm path length quartz 
cuvettes on Varian Cary 50 spectrophotometer. λmax (H2O) = 516 nm (SPR), Diameter = 
12 ± 3 nm (DLS number distribution), PDI = 0.1,  
ζ-potential = -46 ± 16 mV.  
2.1.1.2. Coating of AuNP Colloid with RuS12 and Characterisation.  
The concentration of the AuNP colloid was changed from 1.6 nM to 9 nM by centrifugation 
at 13,000 g for 30 minutes and re-dispersing pellet in 350 µl of deionised water. 10 µl of 
10% Zonyl FSO fluorosurfactant (v/v) was used to coat 1 ml of 9 nM AuNP colloid and 
coating was monitored by measuring the SPR. Once fully coated the solution was 
centrifuged at 13,000 g for 30 minutes and the pellet re-suspended in 1 ml of water to give 
Zonyl coated AuNP (AuNP.Z).  λmax (H2O) = 518 nm (SPR), Diameter = 16 ± 5 nm (DLS 
number distribution), PDI = 0.3, ζ-potential = -50 ± 8 mV. 1 ml of AuNP.Z was coated with 
20 µl of 0.87 mM RuS12 using 2 µl aliquots and sonicating solution frequently, full coating 
was again monitored by a shift in SPR to ensure a full coating of metal complex onto AuNPs 
to give RuS12·AuNP20. The final step was purification of RuS12·AuNP20 by size-
exclusion chromatography on Sephadex G25 and RuS12·AuNP20 was eluted with distilled 
water. A full characterization of RuS12·AuNP20 was performed. TEM and Dynamic Light 
scattering (DLS) was used for characterization by size. λmax (H2O) = 520 nm (SPR), 
Diameter: 22 ± 9 nm (DLS number distribution), PDI = 0.3, ζ-potential = -42 ± 15 mV. 
Stability of RuS12·AuNP20 was carried out by measuring the luminescence lifetime decay 
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as described previously and published by Osborne and Pikramenou, 2015 (I acknowledge 
Shani Osborne for carrying out the experiment on the luminescence lifetime decay, data 
shown in appendix 2B). An emission scan of RuS12·AuNP20 at excitation wavelength of 
488 nm was done to prove its luminescence property. Fully characterised RuS12·AuNP20 























Figure 10 : A schematic representation of coating of AuNP colloid with zonyl and Ruthenium 
complex (RuS12) to give RuS12·AuNP20.  
AuNP colloid was synthesized from the reduction of gold salt in the presence of citrate. The citrate 
stabilized AuNP was firstly coated with 10% Zonyl FSA (a fluorosurfactant) and finally RuS12 (I 
acknowledge Shani Osborne for synthesizing ruthenium complex). Image adapted from (Osborne 
& Pikramenou, 2015) 
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2.2 Cell Culture.  
2.2.1. Cell Type. 
The A549 cells are Human lung adenocarcinoma epithelial cell line initiated by Giard et al. 
(1973) through explant culture of lung carcinomatous tissue from a 58-year-old Caucasian 
male. A549 cell line is grown in the lab as a monolayer adherent cell attached to culture flask 
and its acts very well as a transfection host (Marzbali et al., 2016; Mu et al., 2016) and also 
it is a well suited model for study of AuNP cellular uptake mechanism and trafficking (Capel 
et al., 2016). The A549 cell line is a widely used cell line for the study of nanoparticles 
uptake, localisation and toxicity (Chang et al., 2011; De Marzi et al., 2014; Kim et al., 2012) 
therefore making it a good model cell line for this current study.  
2.2.2. Cell Culture Technique. 
A549 cells which were cryopreserved at a very low passage of 3 in our laboratory were 
thawed and used throughout this project. Thawed cells were cultured in aseptic environment 
using a lamina flow hood and grown in a humidified atmosphere (5% CO2 incubator; 95% 
air) at 37°C. 
2.2.2.1. Sub-culturing. 
Cells were maintained by growing in a vented cap T75 flask at 37°C in Dulbecco's modified 
Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-
glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin, hereafter called complete 
media. Media was replaced every 3-4 days and cells sub-cultured once they had reached 
approximately 70% confluence using a standardised trypsin-ethylenediamintetraacetic acid 
(EDTA) protocol. Briefly, cells are washed twice with 10 ml of phosphate buffer saline 
Solution (PBS), detached with 3 ml of trypsin-EDTA and harvested with 9 ml of complete 
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media. Cells were then centrifuged at 1500 g for 5 minutes, the supernatant discarded and 
the pellet re-suspended in 1 ml of complete media. The cell suspension was then sub-cultured 
at a ratio of 1:4 into a 15 ml complete media in new T75 culture flask. 
2.2.2.2. Cell Counting by Haemocytometer. 
Cells used in all experiments were counted using a haemocytometer. After centrifugation 
and re-suspension of the cell pellet in 1 ml of complete media, a 15 µl aliquot is diluted 1:1 
with 0.4 % trypan blue and cells counted using a 10X magnification of light microscope. 
Only cells in the middle grid are counted and they are counted in duplicate. The average 
count was then used to calculate the number of cell in the 1ml suspension and cells are seeded 
at the appropriate density for the experiments as described in subsequent sections. 
2.3. Uptake of RuS12·AuNP20 in A549 cells.  
Uptake of RuS12·AuNP20 into A549 cells was studied over a period of 2-72 hours using 
multiple techniques (confocal imaging, transmission electron microscopy and inductively 
coupled plasma-mass spectrometry). The concentration used (0.9 nM of RuS12·AuNP20, 
which is equivalent to 10% dilution of 9 nM RuS12·AuNP20 with complete media) was 
based on previously published result (Rogers et al., 2014) in our lab that gave best ratio of 
nanoparticles to media dilution without being toxic to the cells.  
2.3.1 Confocal Microscopy.  
Uptake of RuS12·AuNP20 into A549 cells by confocal microscopy was investigated using 
a Leica SP2 confocal system with 63X and 100X oil immersion objective lens. Images were 
acquired in fluorescence, reflectance and transmission mode. Fluorescence channels were 
acquired with the following excitation and emission:   
 Hoechst (Thermofisher) (blue channel): λexc = 405 nm (75%), λem = 410-455 nm. 
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 Nanoparticle luminescence (red channel): λexc = 458 nm (100 %), 476 nm (100%), 
488 nm (100%) 496 nm (100%) and 514 nm (57%), λem = 620 -800 nm 
 GFP (green channel) 488 nm, em = 502 nm.  
Reflection images were acquired at λexc = 488 nm (67%), λem = 478 -498 nm and 
transmission images were acquired using the default transmission setup of the microscope 
with beam intensity 1-3 %. Images were acquired on both live cell and fixed cell. All images 
acquired were processed by imaging software (ImageJ Version 1.43M) details in Appendix 
2C. Confocal imagining were carried out in biological triplicate and controls were cells not 
treated with nanoparticles. The first and second duplicate for confocal imaging were used to 
optimize the conditions for the experiments and imaging, only the result of the third triplicate 
were reported. 
2.3.1.1 Live Cell Imaging.  
Cells were seeded at a density of 100,000 into a 35 mm dish with a 10 mm glass diameter 
insert and allowed to attach overnight. The next day, cells were rinsed with PBS and then 
treated with 3 ml of media containing 0.9 nM RuS12·AuNP20 for 2, 4, 8, 12, 24, 48 and 72 
hours. At the end of each time point, spent media was aspirated and cells rinsed three times 
with PBS followed by 30 minutes treatment with 2.5 µg/ml Hoechst 33258. Cells were 
finally rinsed three times with PBS and imaged in live cell imaging solution (Thermofisher).  
2.3.1.2. Fixed Cell Imaging.  
Cells were seeded at a density of 100,000 onto a sterilised 22 mm diameter cover-glass in a 
6-well plate and allowed to attach overnight. The next day cells were rinsed with PBS and 
then treated with 3 ml of media containing 0.9 nM RuS12·AuNP20 for 2, 4, 8, 12, 16, 24, 
32, 40, 48, 56, 64 and 72 hours. At the end of each time point, spent media was aspirated 
and cells rinsed three times with PBS followed by fixation with 4% paraformaldheyde (4% 
PFA) for 15 minutes at room temperature. After fixing, cells were further rinsed two times 
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with PBS and stained with 1 µg/ml Hoechst 33258 for 10 minutes. Cells were then rinsed 
twice with PBS followed by mounting to glass slide with a drop of Hydromount media 
(National diagnostics). Slides were stored for 24 hours at 4oC before imaging. For each time 
points, 10 random different images were acquired per slides and used for image processing.  
2.3.2. Transmission Electron Microscopy. 
Cells were seeded at a density of 100,000 on to a sterilised 13 mm diameter coverglass in a 
6-well plate and allowed to attach overnight. The next day cells were rinsed with PBS and 
then treated with 0.9 nM RuS12·AuNP20 for 2, 4, 8, 24, 48 and 72 hours. At the end of each 
time point, spent media was aspirated and cells rinsed three times with PBS followed by 
fixation with 2.5% glutaraldehyde for 24 hours at 40C. Samples were taken for processing at 
Centre for Electron Microscopy (University of Birmingham). Ultrathin sections of between 
70-90 nm were cut parallel to cover-glass and mounted onto formvar-coated 200 mesh 
copper grids. Images were acquired with Jeol 1200 EX transition electron micrograph 
operated at 80kV in imaging mode. Images were acquired using Digital Micrograph Version 
1.83.842. TEM imaging was carried out as a biological duplicate, the first duplicate was used 
to optimize the settings of the microscope, while the second duplicate were prepared as 
technical duplicate and the result were reported.  
2.3.3. Inductively Coupled Plasma Mass Spectrometry (ICP-MS). 
Cells were seeded at a density of 100,000 cells per well in a 6-well plate and left overnight 
for attachment to occur. Spent media was aspirated and replaced with 3 ml of complete media 
containing 0.9 nM, RuS12·AuNP20 and treated for 2, 4, 8, 12, 16, 24, 32, 40,48, 56, 64 and 
72 hours.  At the end of each time point, spent media was removed and cells washed three 
times with 1 ml of PBS. Cells were detached by treating with 1 ml of trypsin for 10 minutes 
and pelleted by centrifuging for 10 minutes at 1500 g. The cell pellets were dissolved in 300 
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µl of ultra-pure aqua regia (3 HCl: 1 HNO3) and left to digest overnight at room temperature. 
The next day, digested samples were diluted with 4% HNO3 to reduce the aqua regia content 
to less than 4% and samples were analysed at analytical chemistry lab at the University of 
Warwick. ICP-MS experiment was done as a biological triplicate with three technical 
trplicate. A series of standard solutions (0, 0.2, 0.5, 1, 2, 5, 10, 20 ppb) containing metals to 
be detected (gold and ruthenium) was used for calibration and determining metal content 
taken up by cells in each sample.  
2.4. Organelle Localisation Studies Using Fluorescent Probes 
2.4.1. Golgi: GOLGI ID® Green assay: 
Co-localisation of RuS12·AuNP20 with golgi was studied with A549 cells grown on cover 
slips in a 6–well plate and treated for 4, 8, 12, 16 and 24 hours with 0.9 nM RuS12·AuNP20. 
The preparation and staining method followed, was according to manufacturer protocol with 
slight modification. Briefly, 1 X assay solution was prepared by the addition of 1 ml of 10 
X assay buffer 1 to 0.2 ml 50 X assay buffer 2 into 8.8 ml of distilled water. 100 µl of 1X 
assay solution was added to a vial containing lyophilised GOLGI-ID® green detection 
reagent (50 nM) to give 100 X GOLGI-ID® green dye solution. Dual detection reagent was 
prepared using Hoechst 33342 nuclear stain included in the kit by 1:100 dilution with 100X 
GOLGI-ID® green dye solution. At the end of each time point, cells were rinsed three times 
with 1 X assay solution and treated with dual detection reagent for 30 minutes at 4°C. Stained 
cells were washed with ice-cold media, treated in complete media for a further 30 minutes 
and followed by final rinsing, fixing and mounting of cover slip to slide for imaging. The 
experiment was done as a biological duplicate. The first duplicate was used to optimize the 
conditions for the experiments and imaging, only the result of the second duplicate was 
reported. 
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2.4.2. Mitochondria: MitoGreen.  
Co-localisation of RuS12·AuNP20 with mitochondria was studied with A549 cells grown 
on cover slips in a 6–well plate and treated for 4, 8, 12, 16 and 24 hours with 0.9 nM 
RuS12·AuNP20. 200 µM stock solution of dye was prepared from lyophilised product using 
DMSO according to manufacturer instructions. To optimise the concentration and duration 
of staining various concentrations between 20-200 nM and 5-30 minutes respectively was 
tested.  At the end of each time point, cells were rinsed, fixed with 4% PFA for 10 minutes 
and stained with 200 µM MitoGreen for 10 minutes (optimised conditions), followed by 
additional staining with 1 µg/ml Hoechst 33258 for 10 minutes before mounting and 
imaging. The experiment was done as a biological duplicate. The first duplicate was used to 
optimize the conditions for imaging, only the result of the second duplicate was reported. 
2.4.3. Endoplasmic reticulum:  ER-Tracker™ Green.  
Co-localisation of RuS12·AuNP20 with endoplasmic reticulum was studied with A549 cells 
grown on cover slips in a 6–well plate and treated for 4, 8, 12, 16 and 24 hours with 0.9 nM 
RuS12·AuNP20. 1mM stock solution of dye was prepared from lyophilised product using 
DMSO according to manufacturer instructions. At the end of each time point, cells were 
rinsed three times, and stained with 1 µM of ER-Tracker™ Green diluted with Hank’s 
Balanced Salt Solution (HBSS) followed by 30 minutes treatment at 37˚C.  Cells 
were fixed using 4% PFA for 2 minutes at 37˚C and stained with 1 µg/ml Hoechst 33258 for 
5 minutes before mounting and imaging. The first duplicate was used to optimize the 
conditions for imaging, only the result of the second duplicate was reported. 
2.5. Organelle Localisation by Transfection of A549 Cell Line with 
Tagged Organelle Specific Markers. 
GFP-tagged organelle specific markers were visualised by transiently transfecting 
plasmid DNA into A549 cells. Plasmids were isolated from frozen glycerol stocks of E. 
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coli previously transformed in our laboratory. The organelle marker plasmid used for this 
research were; human lysosomal associated membrane protein (LAMP1) representing 
lysosome; human RAB4A, member RAS oncogene family (RAB4A) representing early 
endosome; human microtubule associated protein (LC3) representing autophagosomes in 
transfected cells. Each of these organelle marker plasmids allows direct visualization of 
organelles without additional staining procedure. The expression vector for all organelle 
markers was pCMV6-AC-GFP vector shown in Figure 11 and all organelle markers are 
turboGFP tagged. 
                      
Figure 11 Schematic of the pCMV6-AC-GFP expression vectors 
This vector contains the CMV promoter, which can be used to express the cloned cDNA. The Kozak 
sequence that drives protein expression in mammalian cell. The C-terminal tGFP tag.  The PolyA 
signal located downstream of the signal. The SV40 ori allows the replication in mammalian cells, 
The Neor that confers the selection of plasmid in mammalian cell. The ColE1 is the bacterial origin 
of replication. The Ampr gene that confers the selection of the plasmids in E.coli and the fi ori is the 
filamentous phage origin of replication, allowing the recovery of single-stranded plasmids. Image 
taken from origene.com 
2.5.1 Preparation of Luria-Bertani (LB) Broth and Agar Plates.  
LB broth and agar plates were used to grow bacteria recovered from frozen bacteria stock. 
LB broth was prepared by dissolving 10 g of LB broth medium into 500 ml of deionised 
water while 1.2% LB agar was prepared by dissolving 6 g of agar and 10 g of broth into 500 
ml of deionised water, both media were sterilised by autoclaving at 1200C for 20 minutes. 
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Both LB broth and agar plates were poured in a sterile environment, which was cleaned with 
70% ethanol and loop flamed with Bunsen burner.  
2.5.2 Bacteria Recovery.  
A sterile pipette tip was used to scrape the top of frozen bacteria from glycerol stock, while 
avoiding thawing of bacteria. The sterile tips were then placed into tubes containing LB 
Broth (5 ml) with appropriate antibiotic; ampicillin (100 µg/ml) for LAMP1 and RAB4 or 
kanamycin (25 µg/ml) for LC3. Bacteria cultures were incubated at 37°C with shaking (270 
RPM) overnight. Overnight cultures of bacteria were plated on LB agar plate at various 
dilutions of broth (1, 1:10, 1:100, and 1:1000) on agar plates, which were inverted and 
incubated at 37°C overnight. The 1:1000 dilution of LB broth and bacteria gave the best 
density of colony with less background lawn and was therefore used to make up a new set 
of glycerol stock (40% glycerol to 60% autoclave dH20). Well-isolated colonies were picked 
at random using a pipette tip and placed in tube containing 5 ml of antibiotic containing 
Broth. Bacterial cultures were incubated in a shaker overnight at 37°C and 270 RPM to 
amplify colonies for plasmid mini-prep. 
2.5.3. Plasmid Mini-Prep. 
Mini-prep on overnight bacteria culture was carried out using QIAprep Spin Miniprep Kit 
(Qiagen). Overnight bacteria cultures were centrifuged for 10 minutes at maximum speed of 
13,000 RPM with a bench top centrifuge to pellet cells.  Pellets were re-suspended in 250 µl 
re-suspension buffer, 250 µl lysis buffer, 350 µl neutralization buffer and centrifuged for 10 
minutes at 13,000 RPM. Supernatants were transferred to a spin column placed in a 
collection tube, centrifuged for 1 minute. 500 µl of wash buffer A and 700 µl of wash buffer 
B was added to spin column, centrifuged at maximum speed to remove all traces of ethanol. 
Spin column was placed in a new elution tube and 50 µl of elution buffer was used to elute 
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plasmid DNA. DNA quantification was done on isolated plasmid DNA to determine purity 
and concentration by NanoDrop ND1000 spectrophotometer. Isolated plasmid was stored at 
-800C until needed. 
2.5.4. Transient Transfection. 
A549 cells were seeded at a density of 60,000 in a 6- well plate and left to attach overnight. 
Confluence was about 50 % the next day and cells were transfected according to 
manufacturer instructions (Origene). Briefly, 9 µl of Turbofectin 8.0 (Origene) was added to 
300 µl of serum free DMEM followed by the addition of 3 µg of isolated plasmid DNA and 
gently pipetting of mixture. The transfection mixture was incubated at room temperature for 
25 minutes followed by drop-wise addition to cells. Plates were gently shaken to ensure 
homogenous transfection and left to incubate at 370C for 48 hours. 48 hours post-
transfection, cells were treated with 0.9 nM RuS12·AuNP20 for 4-72 hours for study of co-
localisation with specific organelle marker. At the end of each time points, cells were fixed 
with 4% PFA and mounted on a glass slide for confocal imaging. Images are acquired as 
described in section 2.3.1 above and analysed for co-localisation using JACoP plugin (Just 
Another Co-loclaisation Plugin) for ImageJ software.  
2.6. Protein Extraction. 
Cells were seeded at a density of 400,000 in a T25 flask and allowed to achieve approximately 
60% confluence before treatment with 0.9 nM RuS12·AuNP20 for 2, 4, 8, 12, 16 and 24 
hours. At the end of each time point, cells were washed three times with PBS and trypsinised 
with 0.5 ml of trypsin for 5 minutes at 370C. The supernatant was discarded and the pellet 
stored at -800C until required. Frozen pellets were thawed and incubated on ice with regular 
vortexing and pipetting for 20 minutes with 250 µl of radioimmunoprecipation (RIPA) 
buffer (1 M Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5 M EDTA, 10% w/v 
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sodium deoxycholate and 10% SDS) supplemented with 0.01 % mammalian protease 
inhibitor cocktail (PhI) added just before use.  After 20 minutes, cells were centrifuged for 
15 minutes at 14,000 RPM and 40C. Supernatant (2 µl) containing protein was used for 
protein quantification by Bradford assay and the remaining, stored at -800C for western 
blotting.  
2.6.1 Protein Quantification by Bradford Assay.  
BioRad sterilised Bradford reagent (1ml of 1X filtered solution) was added to all cuvettes 
(standard and sample). To the standard cuvette, 0, 1, 2, 4, 6, 8 and 10 µl of 1 mg/ml bovine 
serum albumin (BSA) was added and to the sample, 2µl of sample (supernatant containing 
protein) was added. The cuvettes were gently mixed to ensure a homogenous solution and 
absorbance measured at 595 nm using 1 ml of Bradford reagent as blank. Protein 
concentration of samples were read from the standard curve obtained.  
2.6.2 Western Blotting  
Total protein (40 µg) was mixed with an equal volume of 2X Laemelli sample buffer and 
denatured by heating at 950C for 5 minutes. Samples were then loaded into wells made with 
4 % stacking gel (4% acrylamide, 125 mM Tris-HCl pH 6.8, 0. 1% SDS, 1 µl/ml TEMED 
and 10 µl/ml ammonium persulfate) and 12. 5% resolving gel (12.5% acrylamide, 375 mM 
Tris-HCl pH 8.8, 0.1% SDS, 1.5 µl/ml TEMED and 15 µl/ml ammonium persulfate) and 
samples ran for 90 minutes at 120V. Separated proteins were transferred onto 0.2 µm PVDF 
membrane (Bio-rad Trans-Blot® Turbo™ Mini PVDF) using a Trans-Blot® Turbo™ 
transfer starter system (Bio-rad). The PVDF membrane was blocked with blocking buffer 
5% (w/v) BSA in [0.1% TBST (Tris buffer Saline and 0.1% Tween-20)] for 1 hour on rocker 
at room temperature to stop any non-specific binding. This was followed by overnight 
incubation with primary antibody LC3 raised in rabbit (cell signalling technology) diluted 
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with blocking buffer 1:1000 and ß-actin raised in mouse (used as housekeeping control 
genes) diluted with blocking buffer 1:10,000 all at 40C with gentle shaking. Membranes were 
washed three times for 10 minutes each, with 0.1% TBST on a rocker at room temperature, 
before incubating with secondary antibody. Secondary antibodies used were all horseradish 
peroxidase (HRP) conjugated and diluted with blocking buffer 1:5000 with sheep anti-rabbit 
antibody (Bio-Rad) for LC3 primary protein and 1:1000 with goat anti-mouse for ß-actin 
(Life technologies) and incubate at room temperature for 1 hour on a rocker. Membranes 
were washed twice for 10 min with TBST and once with TBS before protein detection using 
SignalFire™ ECL Reagent (Cell Signalling Technology) and Amersham Hyperfilm (GE 
healthcare). The film was exposed for 5 minutes and developed using a XoGraph machine 
(AGFA Curix 60).  
2.7. Ribonucleic Acid (RNA) Extraction and Quantification.  
Cells were seeded at a density of 100,000 in a 6-well plate and left to attach overnight before 
treatment with 0.9 nM RuS12·AuNP20 for 4, 8, 16, 24, 48 and 72 hours. At the end of each 
time point, cells were washed three times with PBS, trypsinised for 5 minutes and 
centrifuged for 5 minutes at 1500 g. Cell pellet were stored in 500 µl RNAlater until required.  
RNA extraction was done using an RNA extraction kit (Qiagen) according to the 
manufacturer instructions. Briefly, cell pellets were thawed on ice and centrifuged to get rid 
of RNAlater and to obtain solid cell pellets. Next pellets were lysed with 350 µl of buffer 
RLT and 350 µl of 70% ethanol (dissolved in RNAase-free water), and the solution was 
pipetted up and down to lyse the cells. The solution 700 µl of was transferred to a spin 
column in a 2 ml collection tube and centrifuged for 8,000 RPM on a bench-top centrifuge 
for 1 minute followed by the addition of 700 µl of buffer RW1 to the spin column (flow 
through was discarded) and further centrifuged for 1 minute at 8,000g (flow through 
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discarded). Buffer RBE of 500 µl of was added to spin column and centrifuged for 2 minutes 
and flow through discarded. Spin column was placed in a 1.5 ml collection tube (RNAase-
free water) and RNA was eluted using 40 µl of RNAase-free water added directly to the 
column, allowed to stand for 1 minute and centrifuged for 1 minute. Concentration and purity 
of extracted RNA was determined by Nanodrop ND1000 spectrophotometer and stored at -
800C until needed.  
2.7.1. Complementary DNA (cDNA) Synthesis 
 cDNA was synthesised from extracted RNA using a Tetro cDNA synthesis kit (Bioline). 
All solutions used were briefly vortexed and all preparation were done on ice. Extracted 
RNA of 500 ng was added to the premix solution. The Premix was made by the addition of 
1µl of oligo (dT) primer, 1 µl of 10 mM dNTP mix, 4 µl 5X RT buffer, 1 µl RiboSafe RNAse 
inhibitor and 1 µl of Tetro Reverse Transcriptase. Premix solution containing RNA was 
mixed gently by pipetting. The solution was then incubated at 450C for 30 minutes and the 
reaction terminated by incubating at 850 C for 5 minutes. Samples were then chilled on ice 
before storing at -200C until needed.  
2.7.2. Quantitative real-time PCR (RT-PCR).  
RT-PCR was done using 250 ng of cDNA, 1µl TaqMan® Gene Expression Assay 
primer (Applied Biosystems,) and 10µl of TaqMan® Fast Advanced Master Mix 
(Applied Biosystems) made up to 20 µl with RNAse-free water. The RT -PCR run, consisted 
of one cycle (polymerase activation) at 950C for 20 seconds, then 40 cycles of denaturing at 
950C for 1 second and annealing at 600C for 20 seconds. The data was collected at the 
annealing stage. All primers (TaqMan® Gene Expression Assay) used were FAM 
labelled and from human species, β-actin was chosen as the housekeeping genes based on 
result of western blot. All experiments were done using three biological replicate for each 
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time points and included three technical replicates. Data analysis was by ∆∆Ct method 
(Pfaffl, 2001). 
 
Gene Symbol UniGene ID 
Microtubule 
associated protein 1 





Heat shock protein 







Catalase CAT Hs.502302 
Table 2: Gene used in RT-PCR  
2.8. Cytotoxicity Assay of RuS12·AuNP20 in A549 cells.  
The biochemical effect of RuS12·AuNP20 on A549 cells was investigated by assessing cell 
viability (MTT and crystal violet) generation of ROS (H2DCF-DA assay), oxidative stress 
(glutathione assay) and single strand DNA damage by (comet assay) at different 
concentrations and different exposure times. RuS12·AuNP20 (9 nM) was diluted 1:10 with 
media to make a stock solution (0.9 nM) and stock solution was serially diluted 1:2, 1:4, and 
1:8 with media to give 0.45 nM, 0.225 nM and 0.1125 nM respectively. Each assay had a 
negative control (A549 cells grown in complete media and not exposed to any nanoparticles) 
and an appropriate positive control. All assays were done in biologically triplicates.  
2.8.1. 3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide) 
MTT Assay. 
Cell viability was measured by the MTT assay, a metabolic assay that measures 
mitochondria activity. MTT powder was made to a stock solution of 5 mg/ml in PBS and 
used at a final concentration of 0.5 mg/ml in media. The presence of mitochondrial 
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dehydrogenase in viable cells allows the reduction of MTT to a purple formazan precipitate, 
which upon addition of DMSO can be quantified colometrically.  
Cells were seeded at a density of 8,000 cells per well in a flat clear bottom 96-well plate and 
left overnight for attachment to occur. Spent media was aspirated and replaced with 100 µl 
of complete media containing 0.9 nM, 0.45 nM, 0.225 nM and 0.1125 nM of 
RuS12·AuNP20 and incubated for 24, 48 and 72 hours at 370C. One hour before the end of 
the time points, positive control cells were treated with 0.15 % (v/v) Triton X-100. At the 
end of each time point, cells were washed three times with PBS and incubated for 3 hours at 
370C with 100 µl of media containing 0.5 mg/ml MTT. Media was removed and formazan 
precipitate was dissolved with 200 µl of DMSO. The absorbance of dissolved formazan was 
determined at 590 nm in a plate reader (Tecan Infinite® 200 PRO) Cell viability was 
expressed as a percentage control of (average mean- DMSO blank) ± SEM.  
2.8.2. Crystal Violet Staining. 
Crystal violet staining (CVS) is a quantitative assay used to determine cellular viability by 
staining the DNA of adherent cells, which are then solubilised with acetic acid. Cells were 
seeded at a density of 15,000 cells per well in a 24-well plate and left overnight for 
attachment to occur. Spent media was aspirated and replaced with 500 µl of complete media 
containing 0.9 nM, 0.45 nM, 0.225 nM and 0.1125 nM of RuS12·AuNP20 and incubated for 
24, 48 and 72 hours at 370C. One hour before the end of the time points, positive control 
cells were treated with 0.15 % (v/v) Triton X-100. At the end of each time point, cells were 
rinsed with 500 µl of PBS and stained with 1% crystal violet (w/v 5% ethanol in distilled 
water) for 30 minutes at room temperature. Stained cells were carefully washed three times 
with water and allowed to air dry for 3 hours at room temperature. Acetic acid (10%) 500 µl 
was added to each well to solubilise the crystal violet and 100 µl from each wells was 
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transferred to a fresh 96 well plate. Absorbance was read at 570 nm against a 10% acetic 
acid blank. The results were expressed as % control of (average mean- 10% acetic acid 
blank) ± SEM.  
2.8.3 Dichloro-dihydro-fluorescein Assay. 
The dichloro-dihydro-fluorescein diacetate (H2DCF-DA) assay is used for the detection of 
reactive oxygen species (ROS). 2′,7′-dichlorodihydrofluorescin (H2DCF) is sensitive to 
several ROS and is oxidised to a fluorescent 2′,7′-dichlorofluorescin (DCF) (Chen et al., 
2010). DCFH-DA penetrates the membrane, and then it is hydrolysed by cellular esterases 
and converted via oxidation to DCF. Therefore, DCF fluorescent indicates the resultant 
oxidative stress due to overproduction of ROS. H2DCF-DA powder was made to a stock 
solution of 10 mM in 100% ethanol and used at a final concentration of 10 µM in media. 
Cells were seeded at a density of 8,000 cells per well in a white clear bottom 96 well plate 
and left overnight for attachment to occur. Spent media was aspirated and replaced with 100 
µl of complete media containing 0.9 nM, 0.45 nM 0.225 nM and 0.1125 nM of 
RuS12·AuNP20 and incubated for 24, 48 and 72 hours at 370C. One hour before the end of 
the time points, positive control cells were incubated with 200 µM H2O2. At the end of each 
time point, all cells were washed three times with PBS which was then replaced with media 
containing 10 µM H2DCF-DA and incubated for 45 minutes at 370C. At the end of 45 
minutes, cells were washed and fresh PBS added to each well and fluorescence intensity was 
measured at an excitation of 485 nm and emission of 535 nm in a plate reader (Infinite® 200 
PRO, Tecan trading). Unstained cells were read to calculate background fluorescence. Result 
was expressed as % florescence intensity of control calculated by average mean -means of 
unstained cells ± SEM. 
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2.8.4 Glutathione Assay.  
Glutathione (GSH) assay measures the levels of intracellular glutathione. In healthy cells, 
glutathione exist more in its reduced form (GSH), a depletion of GSH indicates cellular 
stress. The levels of GSH was measured in cells treated with RuS12·AuNP20 and read 
against a GSH standard curve (Hissin & Hilf, 1976). Cells were seeded at a density of 
100,000 cells per well in a 6-well plate and left overnight for attachment to occur. Spent 
media was aspirated and replaced with 3 ml of complete media containing 0.9 nM, 0.45 nM, 
0.225 nM and 0.1125 nM of RuS12·AuNP20 and incubated for 24, 48 and 72 hours 370C.  
At the end of each time point, spent media was removed and cells washed with 1 ml of PBS. 
Cells were scraped into 450 µl of ice-cold lysis buffer (0.1% Triton X-100 in PO4-EDTA) 
and placed on ice. The ice-cold protein precipitation buffer (50% trichloroacetic acid in PO4-
EDTA) 50 µl was added to lysate placed on ice which was vortexed first before centrifuging 
with a bench-top centrifuge at 13,000 RPM for 5 minutes and the supernatant used to 
measure GSH levels. GSH levels obtained were read against the standard GSH standard 
curve (GSH standard curve is shown in appendix 5D1) described in section 2.8.4.1 below.  
2.8.4.1. Glutathione Standard Curve.  
PO4-EDTA buffer 1.8 ml (100 mM NaH2PO4 and 5 mM Na2EDTA pH 8.0) was added to a 
3 ml fluorescence cuvettes (standard curve and samples). For standard curve, 
0,1,2,4,6,8,10,12,14,16,18 & 20 µl of GSH (0.1 mg/ml of GSH in PO4-EDTA) was added to 
cuvettes, followed by 100 µl of 5% TCA. To sample cuvette, 100µl of sample (supernatant) 
was added followed by 100 µl of o-phthalaldehyde (1 mg/ml of OPT in 100 % methanol) to 
all cuvettes. Cuvettes were gently mixed and covered for 15 minutes and fluorescence read 
at excitation of 350 nm, emission of 520 nm and slit width set at 5 nm using a PerkinElmer 
LS50B luminescence spectrometer. GSH levels in each sample was expressed as % control 
of reduced glutathione levels ± SEM. 
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2.8.5 Alkaline Comet Assay.  
The alkaline comet assay is a sensitive and quantitative technique for detecting DNA strand 
breaks (Singh et al., 1988). During DNA damage, the supercoiled structure of intact DNA is 
lost and when electrophoresis is applied, DNA damage is observed as a comet-like structure.  
Cells were seeded at a density of 200,000 cells per well in a 6-well plate and incubated at 
370C overnight for attachment to occur. Spent media was aspirated and replaced with 3 ml 
of complete media containing 0.9 nM, 0.45nM, 0.225nM and 0.1125nM of RuS12·AuNP20 
for 24, 48 and 72 hours and incubated at 370C. 
2.8.5.1. Slide Preparation.  
Microscope slides were pre-coated with normal melting point agarose (NMPA; 0.5% w/v in 
PBS) and air dried for at least 48 hours. After incubation, media was aspirated and cells 
washed with PBS and trypsinised with 1ml of trypsin.  Cell pellets were re-suspended in 150 
µl of PBS and 10 µl was aliquoted into tubes containing 150 µl warm low melting point 
agarose (LMPA; 0.5% w/v in PBS).  The resulting mixture (10 µl sample + 150 µl LMPA) 
was added to NMPA-coated slides and slides were chilled on metal tray on ice for about 20 
minutes to enable solidification of the agar. Once the agar had set, coverslips were taken off 
and slides placed into a coplin jar containing lysis buffer (2.5 M NaCl, 0.1 M Na2EDTA, 
110 mM Tris Base and 33.3 ml sodium laurylsarcosinate, in 1 liter of dH20). The coplin jar 
was wrapped in foil and left at 40C for 1 hour. Slides were transferred after an hour of lysis, 
to a large electrophoresis tank containing electrophoresis buffer (9 M NaOH and 20 mM 
Na2EDTA) in a cold room and the DNA is allowed to unwind for 20 minutes. After the 20 
minutes, slides were electrophoresed for 20 minutes at 300 mA and 32 V. Following 
electrophoresis, slides were washed three times with neutralization buffer (0.4 M Tris Base 
pH 7.4) for 5 minutes followed by distilled water for an additional 5 minutes. Slides were 
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stained with 50 µl SYBR gold solution and covered with a coverslip. Slides were then stored 
overnight in moist box at 40C. Slides were scored (100 cells per slides) and comet analysed 
by comet assay IV software. Results are expressed as % control of the mean of the median 
tail intensity ± SEM as opposed to conventionally used mean of mean. This is so because of 
the unequally distribution of the damage in the tail.  
2.9. Statistics  
Raw data generated from experiments were analysed using IBM SPSS software version 21. 
First, was to test the normality of all data. Normally distributed datasets were subject to 
parametric testing: one-way analysis of variance (ANOVA) and Bonferroni Post Hoc 
analysis. Non-normal datasets were analysed with Kruskal-Wallis tests. All experiments 
were biological triplicate with a minimum of two technical duplicates. Data are expressed in 
graphs, graphs were prepared using Microsoft office excel 2016. The level of significance 





Chapter 3  
Characterization of 
RuS12·AuNP20 and Uptake in 
A549 cells 
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3.1. Introduction  
The potential biomedical applications of AuNPs are highly dependent on their physical and 
chemical properties. These properties of AuNPs need proper characterization to ensure 
continuous uniformity in synthesis. Therefore, establishing a proper characterization profile 
of particles is essential before any cellular studies. Characterization of AuNPs as well as 
functionalised AuNPs involves understanding features such as surface area, solubility, 
particle size distribution, aggregation, shape and size of the particles, which are all reliant 
on the surface plasmon resonance (SPR) properties of AuNPs.  
SPR of AuNPs is a very important property because it determines the physical properties 
such as size and shape of AuNP. SPR has been demonstrated to occur between a wavelength 
of 500-550 nm in the visible region, and it varies based on the size and aggregation state of 
AuNP (Jain et al., 2006; Philip, 2008; Zheng et al., 2016). The SPR of AuNP arises from 
the interaction of specific wavelength of light with free oscillating electrons on the surface 
of AuNPs to produce an absorption peak measured by ultraviolet-visible (UV-Vis) 
Absorption Spectroscopy (Ghosh & Pal, 2007). The incorporation of additional surface 
coating onto AuNPs during functionalization causes a shift in absorption peak of SPR 
(Davies et al., 2012; Engel et al., 2017). Therefore, determination of SPR of both AuNPs 
and the functionalised AuNPs (RuS12·AuNP20) is critical for their characterization profile.  
The dependency of the particle size on value of SPR makes size characterization equally 
important. For a particle to be classified as a nanoparticle, it must have a diameter of between 
1 -100 nm as set by the international standard organization (ISO, 2008). TEM imaging and 
dynamic light scattering (DLS) are methods used for size characterization of AuNPs. The 
high electron density of gold makes it easily visible by TEM imaging which can be used to 
measure the diameter of AuNPs (Brust et al., 1994).  
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DLS is a technique often used to measure the hydrodynamic radius of the inorganic core as 
well as additional surface coatings on the core of sub-micron particles present in colloids 
(AuNPs) when they move under the influence of Brownian motion (Mehtala & Wei, 2014). 
The principle behind DLS is measuring the light scatted from the laser that passes through 
the colloid, which is then used to estimate the hydrodynamic size (Berne & Pecora, 2000). 
Using DLS to measure particle size also measures the polydispersity index (PDI) which 
gives the homogeneity of the size distribution. Particles with high PDI (>0.5) consist of 
varying sizes of particles with broad distribution while particles with evenly sized particles 
have a lower PDI (Cho et al., 2013; Lu et al., 2011). The PDI is also a useful indicator for 
confirming the attachment of the ligand to particle and the colloidal stability of 
functionalised ENPs (Masarudin et al., 2015). Colloidal stability is also measured by zeta 
potential. Zeta potential is the potential difference that exists between the particle surface 
and dispersing liquid. A particle with large negative or positive potential will 
electrostatically repel each other while particles with small negative or positive potential will 
attract each other with a tendency to aggregate (Cho et al., 2013). So generally, a 
recommended zeta potential for a stable colloid should be larger than +30mV or less than -
30mV so as to maintain the electrostatic repulsion between the colloid and avoid aggregation 
(Cho et al., 2013).  
AuNP has an intrinsic luminescent property owing to its SPR, which can be altered either 
positively or negatively upon surface functionalization and change in shape or size (Eustis 
& El-Sayed, 2006; Thomas & Kamat, 2003). The functionalization of AuNPs with a 
luminescent molecule such as transition metals specifically ruthenium used in this study 
enhances the overall luminescent property of AuNPs making them an ideal candidate as a 
nanoprobe. RuS12·AuNP20 would therefore bear a distinct optical signature of the 
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ruthenium metal complex, independent of the particle properties (Osborne & Pikramenou, 
2015; Rogers et al., 2014).  
Only fully characterised RuS12·AuNP20 were used for cellular studies by first studying the 
kinetics of uptake in A549 cells in this chapter and trying to decipher the mechanism of 
uptake. Imaging as well as analytically using inductively coupled plasma mass spectrometry 
(ICP-MS) was used to study the uptake of RuS12·AuNP20 and this was done over a period 
of 2-72 hours. Study of uptake by imaging was by confocal, which involved both fixed and 
live cells and lastly TEM. Confocal microscopy of the uptake of RuS12·AuNP20 in A549 
cells was possible because of its luminescent property as confocal microscopy works by 
excitation of light from a laser passing through a pinhole to reject out of focus light and 
producing images from a section of the sample (Sheppard & Shotton, 1997). The limiting 
low resolution of confocal imaging was the reason for supplementing the uptake study with 
TEM imaging. TEM enables detailed imaging of cells because of its high resolution and 
contrast of gold in biological samples. The contrast is possible because gold is a heavy metal.  
ICP-MS is a sensitive technique capable of detecting very small quantity of metals in 
samples therefore making it ideal as a quantitative measurement of uptake of 
RuS12·AuNP20 in A549 cells. The work in this chapter presents a detailed characterization 
of RuS12·AuNP20 and the study of their uptake in A549 cells over 2-72 hours using various 
technique such as imaging and ICP-MS.  
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3.2. Results  
3.2.1 Characterisation of RuS12·AuNP20 
The protocols for preparation and functionalization of RuS12·AuNP20 were performed 
according to Osborne and Pikramenou (2015) and the characterization data generated are in 
agreement with published data.  
The SPR of synthesised citrate stabilised AuNP colloid was measured first, followed by the 
concentrated AuNP. The concentrated AuNP showed an increase in SPR from 516 to 517 
nm (table 3) indicating a more concentrated solution than the originally synthesised citrate-
stabilised AuNP colloid (1.6 nM to 9 nM). The concentrated AuNP was first coated with 
zonyl, a fluorosurfactant and a SPR shift from 517 to 518 nm (Table 3 and Figure 12) was 
observed. The zonyl coated AuNP (Z.AuNP) was isolated by centrifugation and finally 
coated with RuS12 to give RuS12·AuNP20 and SPR shifted from 518 to 520 nm with no 
further shifting indicating a full loading of RuS12 onto AuNP surface. RuS12·AuNP20 was 
purified by size-exclusion chromatography to remove any excess and unbound ruthenium 
complex. The UV-Vis scan of the purified RuS12·AuNP20 gave the same SPR of 520 nm 
confirming the stability of the ruthenium complex on the AuNP surface even after 
chromatography. Purified RuS12·AuNP20 was further characterised for it size and 
luminescence property before use in cellular studies.  
Dynamic light scattering (DLS) and TEM were used for particle size characterisation. DLS 
characterization data is summarised in table 4. The DLS result showed an increase in number 
and intensity distribution upon addition of zonyl and ruthenium complex onto the gold 
surface, indicating their attachment to surface of AuNP. Also the PDI values are quite low, 
indicating particles are monodispersed. All batch of particles used throughout this study had 
a final size (number distribution) of around 20 nm and a PDI of ≤ 0.4.  
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The TEM analysis (Figure 13) of RuS12·AuNP20 showed monodispersed, spherical 
particles of about 20 nm, the TEM analysis was performed and published by Osborne and 
Pikramenou (2015). The TEM analysis and DLS result are in agreement about the size of 
the particle been about 20 nm with no evidence of aggregation.  
The SPR band at about 520 nm observed by UV-vis spectroscopy is an indication of the 
luminescent ability of RuS12·AuNP20. To further, confirm this a luminescence emission 
spectrum of RuS12·AuNP20 excited at 488 nm is shown in Figure 14 with a peak of about 
650 nm which is the red end of visible spectrum (red colour wavelength is between 620-750 
nm). The emission spectra further proves the luminescence property of RuS12·AuNP20, 







Figure 12: Uv-vis absorption spectra coating of citrate stabilised AuNP with RuS12. 
1 ml of citrate stabilized AuNP colloid was coated with 10% zonyl and an increase in absorbance was 
observed. The observed increased in absorbance shows the increase in luminescence of AuNP colloid 
upon the attachment of RuS12. On further coating with RuS12 a further increase in absorbance is 
observed as a 4 nm shift compared to the AuNP colloid indicating the loading of the coatings onto the 




Sample λmax (nm) 
Shift 
(nm) 
Citrate stabilised AuNP colloid  516 0 
Concentrated AuNP colloid  517 1 
Z.AuNP 518 2 
RuS12·AuNP20 520 4 
Purified RuS12·AuNP20  520 4 






































AuNP colloid  12 ± 3 18±5 0.1 
Concentrated 
AuNP colloid  13 ±3 19±5 0.1 
Z.AuNP 16 ±5 31 ±13 0.3 
Purified 
RuS12·AuNP20 22 ± 9 161  ± 110 0.3 
          
Figure 13: TEM image of RuS12.AuNP20 in water.  
The result of the DLS shows the number distribution at 22 nm (Table 4), which is similar to the 
characterisation TEM data gotten and published by Osborne & Pikramenou, 2015, which shows the 
particles to be mono-dispersed and about 20nm.  
 
Figure 14: Luminescence emission spectra of RuS12.AuNP20 in water 
1ml of RuS12.AuNP20 was excited at 488 nm to collect it emission scan, which was shown to be 
about 650. This result is also similar to published data by Osborne & Pikramenou, 2015. Confirming 
the reliabilty of the protocol used in the syntheisize of RuS12.AuNP20 
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3.2.2. Uptake in A549 cells   
Fully characterised RuS12·AuNP20 were used to study the cellular uptake in A549 cells by 
different imaging techniques. 0.9 nM of RuS12·AuNP20, which is equivalent to 1:10 
dilution with media, was the concentration used for the study of uptake. This concentration 
was observed to be non-toxic to A549 cells by MTT Assay (detailed results in chapter 5) 
and from previous investigation in our lab (Rogers et al., 2014) thereby making it a suitable 
concentration for use in cellular studies. The luminescence properties of RuS12·AuNP20 
was exploited for this study especially in confocal imaging while the electron dense 
characteristic of gold was harnessed for TEM imaging.  
3.2.2.1. Confocal Microscopy  
RuS12·AuNP20 uptake in A549 cells were studied over a period of 2-72 hours in fixed cells, 
supplemented with live cell imaging. Live cell imaging was used because the cells are in 
their normal physiological state and to remove possibility of artefact related to the fixation 
procedure. Representative images shown are from major time points: 2, 8, 16 and 48 hours 
(other time points are shown in appendix 3A). The images shown are fluorescence images 
of RuS12·AuNP20 with counterstained nuclei (blue, stained with Hoechst) and the 
corresponding reflection images showing the outline of the cells and RuS12·AuNP20 as 
bright spots. The bright spots of RuS12·AuNP20 in reflection images is as a result of the 
scattering signal of the gold while the luminescent ruthenium complex on the AuNP surface 
is responsible for the red signal on the fluorescence channel, which represents clusters of 
RuS12·AuNP20. Also, shown are overlay images of the fluorescence and reflection 
channels, which the red spot and the white dot overlap indicating the intracellular stability 
of RuS12·AuNP20. Ruthenium complex alone (RuS12) was also imaged in cells after 4 
hours treatment (data in appendix 3B) and the imaging showed a very diffuse staining  
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compared to  nanoparticle (RuS12·AuNP20) images further confirming the stability of 
RuS12 on the gold surface. Unless otherwise stated all scale bar are 20 µm. 
The result of the images shows that at early time point of 2 hours, very few nanoparticles are 
observed in the fluorescence channel (Figure 15a; yellow arrows) and the corresponding 
reflection image shows the particle to be localised on the cell membrane suggesting the 
particles are taken up by the cells at about 2 hours post treatment. Similar observation of 
membrane associated particles at 2 hours was noticed in the live cell imaging (Figure 16) 
therefore, ruling out any chance of it been artefact. Over time, more nanoparticles are 
observed to be taken up by the cells in both fixed and live cell imaging (Figure 15 and 16) 
indicating that the uptake of particles into cells is time dependent. Also observed, the 
particles accumulated and localised in perinuclear region of the cells that is around the 
nucleus evident in both fluorescence and reflection channel irrespective of the time points.  
Having established a time dependent uptake as observed in the confocal images, we aimed 
to quantify the uptake of RuS12·AuNP20 in A549 cells based on acquired images. For each 
time points, 10 different images were acquired and processed as described in Figure 17 with 
details in appendix 2C. The aim of the processing was to quantify the RuS12·AuNP20 by 
counting the number of dots from the red fluorescence channel, which is a representation of 
nanoparticle clusters. The count was done per field of view and the zoom were all corrected 
to one irrespective of zoom used to acquire image to makes the count comparable within 
time points. In addition, acquiring 10 different images helped to increase the precision and 
reduce error. The graph in Figure 18 shows various time points and the average count of 10 
different acquired images. A time dependent increase in count is observed which is expected 
based on the confocal imaging Figure 15 and 16. The count remained almost constant at 
about 40 hours up to 72 hours suggesting a saturation of cells with RuS12·AuNP20 at about 
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40 hours. Therefore, confocal images show that the uptake of RuS12·AuNP20 into A549 
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Figure 15: Representative merged confocal images of major time points of fixed A549 treated with 0.9 nM 
RuS12·AuNP20 and Hoechst. 
A549 cells were treated with 0.9 nM RuS12.AuNP20 between 2-72 hours. The images shown 
are representative of 10 different images acquired per slide (for each time point). This 
experiment was done as a biological triplicate, the first two duplicate were used to optimize 
imaging conditions and showed similar result with the third replicate which are the images 
reported (n=1). An increase in uptake is observed over time and the yellow arrows are 
nanoparticles on the cell membrane (A 2hours c). Only major time points are shown here and 
other time points are in appendix 3A.  
a. Merged images of RuS12·AuNP20 and Hoechst  
b. Their corresponding reflection image (λexc = 488 nm, λ =em = 478-498 nm) a 
c. Merged fluorescence and reflection channel.  
RuS12·AuNP20 emission form red channel (λexc = 488 nm, λem = 620-800 nm) 
Hoechst emission form the blue channel (λexc = 405nm, λem = 410-455 nm) 
  
48  hrs A. 48hrs a 48hrs b 48hrs c 
B. 72hrs a 72hrs b 72hrs c 
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Figure 16: Representative confocal images of live cell imaging of A549 treated with 0.9 nM  RuS12.AuNP20  
Live cell imaging was done to complement the fixed cell imaging. Imaging was done in live cell imaging solution. 
The experiment was done biological triplicate, the first two duplicate were used to optimize imaging conditions 
and showed similar result with the third replicate which are the images reported (n=1). 
Results were similar to fixed cell especially at 2 hours (yellow arrow) showing nanoparticles on the cell 
membrane and also the increase in uptake of time.  
a. RuS12.AuNP20 emission form red channel (λexc = 488 nm, λem 620-800 nm)  
b. Hoechst emission form the blue channel (λexc= 405 nm, λem = 410-455 nm)  
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Binary image (b) 
Red channel 
 Outline of count (c) 
Figure 17: Steps in quantification of confocal images  
Images acquired by confocal microscopy were subjected to analysis by ImageJ software (Image 
processing software). The red channel (nanoparticle luminescence) was converted to binary images 
(b), each of the dots represents clusters of RuS12.AuNP20 and was counted automatically, and (c) 
shows the outline of particles counted and the number details of procedure explained in appendix 2C. 





Figure 18: Quantification of acquired images of A549 cells treated with 0.9 nM RuS12·AuNP20  
Each time point was represented by a slide, for each time point, 10 random images per slides were 
acquired and processed by counting the red dots, which represent clusters of RuS12·AuNP20. The 
A549 cells used for this imaging were treated with 0.9 nM of RuS12·AuNP20 between 2-72 hours and 
the result shown was from a single experiment with no technical replicate (n=1).  The count was done 
with Image software. The result is expressed as average count ± SEM and shows an increase over 














3.2.2.2. Transmission Electron Microscopy Imaging  
TEM utilises beams of electrons to create an image. The image is formed by the interaction 
of electrons with gold, which provides a good contrast against the biological medium that is 
the cell. In addition, the resolution of TEM is higher in comparison with confocal 
microscope, thereby enabling visualization of individual particles in respect to its cellular 
localisation and monitoring their uptake over time. The TEM images acquired at early time 
points of 2 hours showed the particles to be localised mainly on the membrane (Figure 19) 
which is in agreement with confocal imaging. The particles are observed to be spherical as 
expected based on the size characterisation in water by TEM (Figure 13). Also, noticed is a 
ruffling of the cell membrane at early time points of 2 hours and observed are particles 
adhering to parts of the fragmented cell membrane (Figure 19). The cell membrane 
undergoes conformational changes observed as fragments and protrusion as more evident in 
4 hours compared to 2 hours because of the presence of more particles (Figure 20). The 
reshuffling and protrusion of the cell membrane seen is an indication of the involvement of 
macropinocytosis as a likely mechanism of uptake of RuS12·AuNP20 in A549 cells. 
Additionally, observed are small vesicles near the cell membrane (yellow dashed circles in 
Figure 19 and 20) that have most likely been recently formed from an inward budding of the 
cell membrane indicating the involvement of clathrin-mediated endocytosis, a receptor 
mediated form of endocytosis as another plausible mechanism of uptake. Interestingly at 
later time points (Figure 21), the cell membrane returns back to normal with no more 
observed reshuffling or protrusion and RuS12·AuNP20 is seen localised in vesicles. Both 
imaging techniques are in agreement with perinuclear localisation of particles. It is worth 
noting that irrespective of length of exposure, RuS12·AuNP20 is still observed as spherical, 
monodispersed particles further supporting its stability and reinforcing its lack of 












Figure 19: TEM image of A549 cells treated with 0.9 nM RuS12·AuNP20 for 2 hours.  
Cells shown are from a single experiment, although the slides were prepared in duplicate. Images in both slides 
had similar observation but only one slide was shown. a). RuS12·AuNP20 localised majorly on the cell membrane 
(red arrow). b. Internalised RuS12·AuNP20 in vesicles (purple arrow). c). disruption of cell membrane and 
RuS12·AuNP20 attached to part of cell membrane and yellow circle shows likely recently formed vesicles from 
the cell membrane. 
  






















4Hrs a.  4Hrs b.  
4Hrs c.  4Hrs d.  
Figure 20: TEM image of A549 cells treated with 0.9 nM RuS12.AuNP20 for 4 hours.  
Cells shown are from a single experiment, although the slides were prepared in duplicate. 
Images in both slides had similar observation but only one slide was shown. 
a). RuS12.AuNP20 localised majorly on the cell membrane (red arrow) and some internalised 
in vesicles (purple region). b and c.  Membrane is protruding and RuS12.AuNP20 is being 
internalised in vesicles. d. the membrane closes up after reshuffling and RuS12.AuNP20 is then 
internalised.  
Figure 21: TEM image of A549 cells treated with RuS12.AuNP20 for 72 hours.  
A zoomed image into a vesicle at 24 hours shows the particles to be nicely spherically mono-dispersed 
with no evidence of aggregation and at 72 hours, more particles are observed all in vesicles with still 
no evidence of aggregation or nuclear localisation instead they are localised in perinuclear region.  
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3.2.2.3. Inductively coupled plasma mass spectrometry ( ICP-MS) 
To analytically quantify the uptake of RuS12·AuNP20 in A549 cells and compare it with 
the image quantification method, cells were subjected to same treatment as uptake study by 
imaging that is the same seeding density, length of exposure and concentration of particles 
were all similar for both. Cells were digested with freshly prepared aqua regia and 
concentration of gold taken up by the cells in each sample was measured by ICP-MS.  
The ICP-MS result presented in Figure 22 is a graph showing an increase in gold (Au) 
concentration in a time dependent manner similar to image quantification. The uptake after 
32 hours all the way to 72 hours became almost constant while for the image quantification 
showed no further uptake at about 40 hours all the way to 72 hours. This suggest from both 
methods of quantification of uptake that the cells begin to become saturated with 
RuS12·AuNP20 between 32-40 hours. Unfortunately, we found it was technically 
challenging to measure the concentration of ruthenium complex; the values were low in the 
samples (shown in appendix 3C2). Previous analysis of elemental composition of 
RuS12·AuNP20 in our lab reveals the Ru: Au ratio to be 1:180 (Osborne & Pikramenou, 
2015) and we attributed this large ratio to a plausible reason for the difficultly in measuring 
the ruthenium composition in the samples. The results obtained from the ICP-MS analysis 
was linearly plotted against the counts obtained from the image qualification (Figure 23). 
This was done because both samples were treated in the same way and because ICP-MS is 
a well-known quantification method for measuring uptake of AuNP, so the image 
quantification was validated against it to see if the approach of image quantification is a 
logical way of quantification. The result of the plot of image quantification vs ICP-MS gave 
a R2 value of 0.9285 indicating a high correlation between both techniques. Therefore, image 
quantification by counts can be used as a method for quantifying uptake of AuNP in cells. 
From the results (both imaging and ICP-MS) presented the summary of the quantification of 
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uptake of RuS12·AuNP20 in A549 are: its time dependent and cells are saturated with 
particles at about 32-40 hours after exposure at 370C incubation.   
 
Figure 22: ICP-MS measurement of uptake of 0.9 nM RuS12·AuNP20 in A549 cells 
Cells were treated with 0.9 nM RuS12·AuNP20 and at the end of each time points, cells were digested 
with aqua regia. The digested samples were used for ICP-MS analysis to determine intracellular 
concentration of gold. Result presented is biological triplicate each having a technical triplicate (n=3), 



























































Figure 23: Linear fit of count by microscopy and concentration of Au by ICP-MS.  
Image quantification was done by quantifying the counts from acquired images by confocal 
microscopy and plotted against the concentration of Au measured. Results are expressed as values 



















In biomedical field, the development of luminescent gold nanoprobes as a diagnostic and 
therapeutic agent is a promising alternative to molecular probes especially as an imaging 
agent (Panchapakesan et al., 2011). RuS12·AuNP20 has great potential as an ideal 
nanoprobe, based on the results presented above. The aim of this chapter was to show the 
characterization profile of RuS12·AuNP20 used in the study and the cellular uptake into 
A549 cells. Understanding the cellular uptake helps in understanding subsequent cellular 
process (Alkilany & Murphy, 2010). Different factors affects the cellular uptake of AuNP 
such as size, shape, surface coatings, aggregation state (Chithrani et al., 2006; Dykman & 
Khlebtsov, 2012; Kunzmann et al., 2011; Nativo et al., 2008). To avoid too many variances 
in this study, the characterization of AuNP used for this studied was properly done on each 
batch to ensure similarities in all batch of nanoparticles used.  
The result of the characterization of RuS12·AuNP20 showed the particles to be stable, 
luminescent with an emission in the red region of visible spectrum, spherical uniformly 
shaped and size, mono-dispersed about 20 nm in size (confirmed by both sizing technique: 
DLS and TEM). The characterization data of RuS12·AuNP20 were reproducible making it 
very suitable for continuous cellular study. Imaging of cells exposed to AuNP is an 
established way of understanding their cellular uptake (Pernodet et al., 2006). Most confocal 
images acquired from other studies are used as a qualitative method of assessing cellular 
uptake (Nativo et al., 2008; Shah et al., 2011; Shukla et al., 2005) while image quantification 
is mostly done on TEM images since it enables visualization of individual particles as 
evident in our result and similar studies (Rothen-Rutishauser et al., 2014). The decision to 
quantify the confocal images was to develop an  alternative method to complement another 
quantification method such as ICP-MS (Chithrani et al., 2006). Similar quantification of 
acquired confocal images from the cellular uptake study of AuNP using ImageJ  to assess 
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the scattering intensity of AuNP has been performed by Kim et al. (2015). Although, their 
procedure is a bit different from ours because we counted the fluorescence based on 
RuS12·AuNP20, they created a list of pixel values based on the scattering intensity and set 
a threshold for collection and analysing five different images per experiment. However, both 
method shows that cellular uptake can be quantified by image analysis of confocal images. 
Interestingly, our result for the validation of our method of image quantification obtained by 
plotting a graph of image quantification vs quantification by ICP-MS gave a R2 value of 
0.92. This  w is similar to theirs, which was 0.94, and both showed a linear correlation, 
although the size of their AuNP was smaller (6 nm) than ours, the results were quite similar. 
Confocal image quantification can therefore be used as an additional method for quantifying 
cellular uptake. Having quantified and confirmed the cellular uptake of RuS12·AuNP20, 
establishing the exact mechanism involved is the next step. 
Based on the TEM images, most of the internalised RuS12·AuNP20 were observed to be 
localised in vesicles in a perinuclear fashion (Figure 19, 20 and 21) with no evidence of 
cytoplasmic localisation suggesting that particles are internalised by endocytosis. This 
observed result of vesicular localisation is very similar to many previous studies 
(Brandenberger et al., 2010; Chithrani & Chan, 2007; Nativo et al., 2008; Rothen-
Rutishauser et al., 2014; Wang & Petersen, 2013). Endocytosis involves cells engulfing 
substance for internalization and there are two main types: macropinocytosis and receptor-
mediated endocytosis (Conner & Schmid, 2003). Both have been implicated in the 
mechanism of uptake of AuNP in A549 cells (Brandenberger et al., 2010; Kuhn et al., 2014) 
and in other cell lines (Gunduz et al., 2017; Ng et al., 2015). Macropinocytosis is involved 
in the uptake of solute macromolecules with diameter of about 200 nm while smaller 
particles are internalised by clathrin-mediated endocytosis; the most studied and understood 
type of receptor-mediated endocytosis (Swanson & Watts, 1995; Xie et al., 2017). To 
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ascertain the exact type of endocytosis involved, endocytic inhibitors can be used to 
specifically block these distinct pathways. EIPA inhibits macropinocytosis by blocking 
Na+/H+ exchange located on the membrane and lowering the pH of membrane (Lin et al., 
2014; Masereel et al., 2003). While CPZ inhibits clathrin-dependent endocytosis by 
inhibiting the formation of clathrin coated pits budded from the membrane receptor thereby 
obstructing endosomal delivery (Wang et al., 1993). Our cytotoxicity result of endocytic 
inhibitor for both pathways in A549 cells showed pronounced decreased cell viability 
especially with CPZ compared to EIPA (data in appendix 3D). It has been reported that 
endocytic inhibitors are capable of inducing cytotoxicity at high concentrations as well as 
having no effect on inhibiting pathway of interest (dos Santos et al., 2011; Vercauteren et 
al., 2010). Therefore, their use and conclusion should be reported cautiously. Interestingly, 
in A549 cells, AuNPs and other metallic ENPs have shown inhibition of either clathrin-
mediated and/or macropinocytosis endocytosis using CPZ and/or EIPA without affecting 
cell viability (dos Santos et al., 2011; Kuhn et al., 2014; Rothen-Rutishauser et al., 2014; 
Wang et al., 2011). The inability to conclude using endocytic inhibitors to ascertain the type 
of endocytosis involved in RuS12·AuNP20 cellular uptake in A549 leaves us to qualitatively 
analyse the TEM images to propose the mechanism of uptake.   
The TEM images (Figure 19 and 20) is suggesting that the most prominent form of 
endocytosis occurring is macropinocytosis. This is evident at early time points of 2 and 4 
hours by the membrane ruffling and folding back onto into itself after the uptake of 
RuS12·AuNP20. The schematic in Figure 24 shows the pathway of macropinocytosis, which 
is very similar to what we observed in terms of protrusion, and ruffling of membrane. Similar 
TEM observation of plasma membrane protrusion and distortion on exposure to AuNP has 
been observed in other cell lines (Chithrani & Chan, 2007; Jiang et al., 2008; Mustafa et al., 
2011) as well as in A549 cell line (Rothen-Rutishauser et al., 2014).  
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Figure 24: Pathway of macropinocytosis  
Macropinocytosis involves the re-arrangement of plasma membrane to form ruffles that later re-joins 
to the plasma membrane by fusion and form a macropinosomes. The maturation process of 
macropinosomes involves extensive tabulation before forming a spherical mature macropinosomes. 
The content of the macropinosomes is usually trafficked to the lysosomes or sometimes recycled back 
to the plasma membrane. The black line represents the involvement of the cytoskeleton.  Image was 
adapted from (Lim & Gleeson, 2011).  
 
Interestingly, macropinocytosis is known to be associated with uptake of large molecule of 
about 200 nm but our TEM evidence suggests that the cellular uptake of 20 nm 
RuS12·AuNP20 is probably by macropinocytosis. This observation can be attributed to the 
fact that during the cellular uptake of particles, they do not get internalised as individual 
particles but as clusters accumulated on the membrane, similar observation of cellular uptake 
by membrane ruffling of clustered AuNPs has been observed (Yang et al., 2013). They 
explained that clustered AuNPs on the membrane achieves a density that triggers cellular 
uptake and stated that both clathrin-mediated endocytosis and macropinocytosis were 
involved in the uptake of AuNPs cluster based on their result of endocytic inhibitors used.  
It is likely that both types of endocytosis are involved in the cellular uptake of 
RuS12·AuNP20 as small invagination of plasma membrane (Figure 19d) synonymous with 
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clathrin-mediated endocytosis were also observed. A number of studies have also shown the 
cellular uptake of 12-25 nm AuNP to be by clathrin-dependent endocytosis (Ng et al., 2015; 
Rattanapinyopituk et al., 2014). Using 15 nm citrate capped AuNP the cellular uptake in 
A549 cells showed both macropinocytosis and clathrin-mediated endocytosis to be in 
involved (Brandenberger et al., 2010), this study is similar to ours in terms of size and cell 
line use. Therefore, this supports our observation of the involvement of both types of 
endocytosis in the cellular uptake of RuS12·AuNP20 in A549 cells.  
In conclusion, we have demonstrated the cellular uptake of 20 nm RuS12·AuNP20 in A549 
cells using various techniques and have been able to quantify the uptake, which was proven 
to increase in a time dependent manner and solely localised in vesicles indicating 
endocytosis as a route of uptake. In addition, we postulate the uptake mechanism to involve 
both macropinocytosis and clathrin–mediated endocytosis with strong evidence. The 







Localisation and Cellular Fate of 
RuS12·AuNP20 in A549 cells 
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4.1 Introduction  
The surface modification of engineered nanoparticles with fluorescence compounds such as 
transition metal complex can result in fluorescent nanoprobes. These nanoprobes have 
advantages in fluorescence imaging over conventional fluorescent probes such as such 
as rhodamine, fluorescein, and cyanine (Comby et al., 2014; Zhang et al., 2016)The surface 
modification of the AuNP used in this research with transition metal complex enables it to 
function as a nanoprobe in fluorescence imaging. For this function and other biomedical 
applications to be fully utilised, understanding the localisation and cellular fate in respect to 
its uptake is crucial. Already established from chapter 3, endocytosis specifically 
macropinocytosis and clathrin-mediated endocytosis is the most likely means of 
internalisation of RuS12·AuNP20 into A549 cells. Most of the internalised nanoparticles 
were localised in vesicles evident from TEM imaging in previous chapter (chapter 3). 
Therefore, it is logical to study co-localisation of RuS12·AuNP20 within organelles involved 
in the endocytic pathway as a means of identifying the intracellular fate of RuS12·AuNP20 
in more details.  
In-vitro localisation of AuNP is usually studied majorly by imaging: either fluorescence 
imaging using confocal microscopy or TEM. In addition, imaging gives an understanding of 
AuNP trafficking within the cell. To study the localisation of RuS12·AuNP20 by confocal 
microscopy, the luminescent properties of the RuS12·AuNP20 were utilised in combination 
with organelle specific stain or transfection of cells with fluorescent-tagged specific 
organelle markers. The emission wavelength of RuS12·AuNP20 is distinctive from the 
emission wavelength of fluorescent organelle markers therefore, for co-localisation to occur 
there must be a fluorescence overlap between the nanoparticle signal and the fluorescent 
organelle. The degree of overlap was measured by Pearson correlation coefficient (PCC). 
PCC has a range of +1 (perfect correlation) to -1 (perfect negative correlation) and 0 which 
 84 
means no correlation (Adler & Parmryd, 2010). Details of the method used to calculate PCC 
is shown in the appendix 4G. TEM imaging supplemented the confocal imaging by 
identifying the specific organelles via their structure, which is a major limit in confocal 
imaging.  
The ultimate aim of studying localisation is to follow the RuS12·AuNP20 in cells overtime 
and hence decipher their cellular fate. Further evaluation of their cellular fate involved 
studying, protein and gene changes in pathways implicated in their uptake and trafficking as 
well as their response. These responses, were studied using western blotting and RT-PCR. 
Western blotting is the most used technique for the identification of specific proteins while 
RT-PCR is a sensitive technique for quantifying gene expression. 
All study was done with a concentration of 0.9 nM of RuS12·AuNP20.  Localisation and 
cellular fate were studied on A549 cells treated with RuS12·AuNP20 between 4-72 hours, a 
mixture of transiently transfected A549 cells and A549 cells stained with specific organelle 
stains were used as model for fluorescent organelles. This chapter aims to understand the 
localisation of RuS12·AuNP20 in A549 by imaging and ultimately their cellular fate by 
western blotting and real time PCR.  
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4.2 Results  
4.2.1. Co-localisation by Confocal Imaging 
The result of co-localisation study presented using confocal imaging involved either 
fluorescent organelle stains or A549 cells that have been transiently transfected with tagged 
fluorescent markers to label the organelle of interest. All organelles studied were GFP tagged 
therefore they showed green fluorescence, while RuS12·AuNP20 has a red fluorescence. 
Co-localisation of RuS12·AuNP20 within an organelle is observed when there is an overlap 
of the green and red signal to produce a yellow signal. Also PCC number(measure of co-
localisation)  for at least 3 images for each time points was generated using an ImageJ plugin 
(Bolte & Cordelieres, 2006). All images presented are a representative of selected time point 
showing the individual red channel (nanoparticle luminescence), green channel (GFP-
organelles), blue channel (Hoechst nuclear stain) and the merged channel. In some cases, the 
reflection channel is also shown to give an outline of the whole cell and show 
RuS12·AuNP20 internalisation within the cell. Control images are also shown. All scale bars 
are 20 µm, unless otherwise stated; refer to section 2.3.1 for microscope setting.  
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4.2.1.1. Golgi Apparatus 
The images shown in Figure 25 are a representative of control cells without any particles but 
stained with Golgi ID dye, which is a dual detection dye that stains both nucleus and the 
golgi. Control A is the fluorescence channel showing the golgi organelle (green) and the 
nucleus (blue). Control B is the equivalent reflection images of A which shows the outline 
of the cells, in the absence of any nanoparticles.  
 
                     
 
              
Figure 25: Representative image of fixed A549 control cells stained with Golgi ID 
A. Merged image of green (GFP emission λexc= 488 nm, λem= 502 nm) and blue channel 
(Hoechst λexc= 405 nm, λem= 410-455 nm).  
B. Corresponding Reflection image (λexc= 488 nm, λem = 478 -498 nm  ) 
Zoomed images below emphasizing on just a cell.  
 
  
Control B Control A 
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When A549 cells are treated with RuS12·AuNP20 from 4 -24 hours, no co-localisation was 
observed with the golgi. The image in Figure 26 is a representative image of A549 cells 
treated with RuS12·AuNP20 for 24 hours to study the co-localisation within the golgi. As 
evident from the reflection and fluorescence images, the particles are clearly internalised and 
localised around the nucleus. The fluorescence images shows the particles to have no co-
localisation with the golgi (green), this is evident in the merged picture (24 hrs M). This 
image is very similar across time points form 4 -24 hours (shown in appendix 4A) for A549 
cells stained with Golgi-ID, therefore it can be concluded that in A549 cells over a period of 
24 hours, RuS12·AuNP20 does not co-localise with the golgi as evident from confocal 
microscopy and PCC value of 0.2.  
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Figure 26 Representative image of fixed A549 treated with 0.9nM RuS12·AuNP20 for 24 hours 
and stained with Golgi ID 
The image shown is a representative image of A549cells treated with 0.9nM RuS12·AuNP20 
for 24 hours. This experiment was done as a biological duplicate and images were all similar, 
showing no co-localisation.    
A. Reflection image (λexc= 488 nm, λem = 478 -498 nm) 
B1. RuS12·AuNP20 emission form red channel (λexc= 488 nm, λem = 620-800 nm). 
B2. GFP emission form green channel (λexc= 488 nm, λem= 502 nm) 
B3. Hoechst emission form the blue channel (λexc= 405 nm, λem= 410-455 nm) 
B4. Merged image of red, green and blue channel. 
Zoomed images showing localisation of particles in spaces between green channel (yellow 
arrow). 
  





The images shown in Figure 27 is a representative image of the study of co-localisation of 
RuS12·AuNP20 with the mitochondria. The mitochondria were stained with MitoGreen and 
the nucleus with Hoechst. Image A of Figure 27 is the control image of just A549 cells 
showing the mitochondria (green) and the nucleus (blue). A representative image of 24 hours 
treatment with RuS12·AuNP20 is shown in Figure 27 B-C4; the reflective image shows the 
outline of the cells and the internalised particles. The fluorescence images (Figure 27 R, G, 
B and M) show the particles, mitochondria, nucleus and the merged images respectively. 
Similar observed with the golgi, the particles do not show any co-localisation within the 
mitochondria evident from images and PCC value of 0.3. The particles appear to be located 
in spaces in between the mitochondria, evident from the yellow arrow. This observation was 
similar across all time points studied (4-24 hours shown in appendix 4B). Therefore, 
RuS12·AuNP20 does not co-localise with the mitochondria.  
 
A. Control   
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C1.24 hours R C2.24 hours G C3.24  hours B C4. 24 hours M B. 24 hours 
Reflection 
Figure 27: Representative image of fixed A549 treated with 0.9nM RuS12·AuNP20 for 24 hours 
and stained with MitoGreen  
The image shown is a representative image of A549cells treated with 0.9nM RuS12·AuNP20 
for 24 hours. This experiment was done as a biological duplicate and images were all similar, 
showing no co-localisation.    
A. Control image of merged green and blue channel.   
B. Reflection image showing A549 cells treated with RuS12.AuNP20  for 24 hours. (λexc= 
488 nm, λem = 478 -498 nm) 
C. Corresponding fluorescence imaging of B.  
C1. RuS12·AuNP20 emission form red channel (λexc= 488 nm, λem = 620-800 nm). 
C2. GFP emission form green channel (λexc = 488 nm, λem = 502 nm) 
C3. Hoechst emission form the blue channel (λexc = 405nm, em = 410-455 nm) 
C4. Merged image of red, green and blue channel. 




4.2.2.3. Endoplasmic reticulum  
The images shown in Figure 28 is a representative image of the study of co-localisation of 
RuS12·AuNP20 with the endoplasmic reticulum (ER). The ER was stained with ER-tracker 
Green and the nucleus with Hoechst. Image A is the control image of just A549 cells showing 
the ER (green) and the nucleus (blue). A representative image of 24 hours treatment with 
RuS12·AuNP20 is shown in Figure 24 B-C4; the reflective image shows the outline of the 
cells and the internalised particles around the nucleus. The fluorescence images (Figure 28 
C1-C4) shows the particles, ER, nucleus and the merged images respectively. As observed 
in previous images with organelle stains (mitochondria and golgi), the particles do not show 
any co-localisation with the ER evident from images and PCC value of 0.1. The particles 
appear to be located in spaces in between the ER similar to the mitochondria. This 
observation was very similar across all time points studied (shown in the appendix 4C). 
Therefore, RuS12·AuNP20 does not co-localise with the ER. 
  





                                                                              
C1. 24 hours R C2. 24 hours G C3. 24 hours B C4. 24 hours M B.24 hours 
Reflection 
Figure 28: Representative image of fixed A549 treated with 0.9 nM RuS12·AuNP20 for 24 hours and stained with 
ER-tracker green.  
The image shown is a representative image of A549cells treated with 0.9nM RuS12·AuNP20 for 24 hours. This 
experiment was done as a biological duplicate and images were all similar, showing no co-localisation.    
A. Control image of merged green and blue channel.   
B. Reflection image showing A549 cells treated with RuS12.AuNP20  for 24 hours (λexc= 488 nm, λem = 478 -
498 nm).  
C. Corresponding fluorescence imaging of B.  
C1. RuS12·AuNP20 emission form red channel (λexc= 488 nm, λem = 620-800 nm). 
C2. GFP emission form green channel (λexc = 488 nm, λem = 502 nm 
C3. Hoechst emission form the blue channel (λexc = 405nm, em = 410-455 nm) 
C4. Merged image of red, green and blue channel. 




4.2.2.4. RAB4: Early endosomes 
The images presented in Figure 29 are representative images of co-localisation of 
RuS12·AuNP20 with A549 cells transiently transfected with GFP-RAB4. RAB4 is an 
organelle marker for early endosome, an organelle that participates in endocytosis of AuNP. 
The co-localisation was studied over a period of (4-24 hours, images in appendix 4D). 
Interestingly, co-localisation was observed only at 4 and 8 hours close to be cell membrane 
(purple arrow) although they had low PCC values of 0.1 and 0.3 at 4 and 8 hours respectively. 
A likely reason for the low PCC despite evidence of correlation is as a result of the software 
designed to calculate the PCC values, which calculates the whole images and not specific 
location. No co-localisation was observed with later time points. Therefore, RuS12·AuNP20 













A. 4 hours Reflection   
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B1. 4 Hrs R   B2.  4 Hrs G   B3.  4 Hrs M   
Figure 29: Representative image of fixed A549 transitenty transfected with GFP-RAB4.  
The image shown is a representative image of A549cells treated with 0.9 nM RuS12·AuNP20 for 4 hours 
after 48 hours transfection with GFP-RAB4. This experiment was done as a biological duplicate and 
images were all similar within time points.  
Reflection image showing A549 cells treated with RuS12.AuNP20  for 4 hours (λexc= 488 nm, λem = 478 
-498 nm). 
Corresponding fluorescence imaging of A.  
B1. RuS12·AuNP20 emission form red channel (λexc= 488 nm, λem = 620-800 nm). 
B2. GFP emission form green channel (λexc = 488 nm, λem = 502 nm). 
B3. Merged image of red and green channel.  




4.2.2.5. LAMP1: Lysosomes 
The images presented in Figure 30 are representative images of co-localisation of 
RuS12·AuNP20 with A549 cells transiently transfected with GFP-LAMP1, an organelle 
marker for lysosome. The co-localisation was studied over a period of (4-72 hours). Co-
localisation (zoomed images) was observed to increase over time from 16 hours to 72 hours 
(other time points shown in appendix 4E) Therefore, RuS12·AuNP20 co-localises with the 
lysosomes, which increases in a time dependent manner and the PCC values also increased 









                                                                                           
1. 16 hours R 2. 16 hours G 3. 16 hours M 
1.  48 hours R 2. 48 hours G 3. 48 hours M 
Figure 30: Representative image of fixed A549 transitenty transfected with GFP- LAMP1. 
The image shown is a representative image of A549 cells treated with 0.9 nM RuS12·AuNP20 for 16 and 48 
hours after 48 hours transfection with GFP-LAMP1. This experiment was done as a biological duplicate and 
images were all similar within time points.  
A. Fluorescence imaging of A549 cells treated with RuS12·AuNP20 for 16  hours.   
B. Fluorescence imaging of A549 cells treated with RuS12.AuNP20  for 48  hours.   
1. RuS12.AuNP20 emission form red channel (λexc= 488 nm, λem = 620-800 nm). 
2.  GFP emission form green channel (λexc = 488 nm, λem = 502 nm). 




4.2.2.6. LC3: Autophagosome 
Autophagosome is an organelle that is highly inducible during various conditions such as 
cellular stress and is believed to be assembled de novo in the cytosol when needed 
(Mizushima, 2007). Autophagosome was chosen as one of the organelles to study for co-
localisation with RuS12·AuNP20 because it is involved in endocytic trafficking and plays a 
role in lysosomal degradation. A549 cells were transiently transfected with GFP-LC3 a 
marker for autophagosome. The image in Figure 31A shows a representative image of 
control cells that has been transfected and not treated with any particle. A diffuse GFP-LC3 
staining is observed indicating the absence of active autophagosomes but on exposure to 
RuS12·AuNP20, a change in staining pattern is observed in time dependent manner. From 
24 hours to 72 hours, the staining pattern changed from diffuse to become more punctuate 
indicating the formation of autophagosomes vesicles. A clear co-localisation (yellow signal) 
evident from the merged images and zoomed images is observed which increases in a time 
dependent manner similar to that observed in lysosome. The PCC values of images shown 
in Figure 31B-D are 0.6, 0.8 and 0.8, which corresponds to 24, 48 and 72 hours respectively. 
Both the images and the PCC show a time dependent increase of co-localisation in the 
autophagosomes. With these results, RuS12·AuNP20 is involved in the induction of 













                                                                                                 
 
                                                                                                                     
B1. 24 Hrs R B2. 24 Hrs G B3. 24 Hrs M 













D1. 72 hours R 
D2. 72 hours G D3. 72 hours M 
Figure 31:  Representative image of fixed A549 transitenty transfected with GFP-LC3.  
The image shown is a representative image of A549 cells treated with 0.9 nM RuS12·AuNP20 for 24, 48 and 72 
hours after 48 hours transfection with GFP-LC3. This experiment was done as a biological duplicate and 
images were all similar within time points.  
A. Control cell: transiently transfected A549 cells with GFP-LC3.   
B-D. Fluorescence imaging of A549 cells treated with RuS12.AuNP20  for 24, 48and 72  hours.  
1.RuS12.AuNP20 emission form red channel (λexc= 488 nm, λem = 620-800 nm). 
2.  GFP emission form green channel (λexc = 488 nm, λem = 502 nm). 
3. Merged image of red and green channel showing co-localisation more evident in zoomed images. Yellow 
signal indicates co-localisation of RuS12·AuNP20 with autophagosomes, which increases over time.  
Zoom 
Zoom      
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4.2.2.7. Summary of the co-localisation by confocal imaging based on 
Pearson’s Coefficient of Correlation. 
All fluorescence images acquired by confocal microscopy were analysed to determine their 
PCC values as a quantitative measure of co-localisation by measuring the correlation 
between the red (RuS12·AuNP20) and green (GFP) signals. The graph in Figure 32 shows 
the summary of the analysis of all 6-organelles studied between 4-24 hours. For each time 
point and organelle, a minimum of three independent images were used for analysis (three 
random images per slide and each slide represents a time point and a specific organelle). 
Time points later than 24 hours were not included in this analysis because only two 
organelles were studied at later time points of 24 hours.  
PCC values typical ranges from 0-1, the closer the value is to one, the higher the correlation, 
hence the greater the co-localisation with the organelle. Based on the fluorescence images 
above, co-localisation was only observed with the lysosomes (GFP-LAMP1) and 
autophagosomes (GFP-LC3) in a time dependent manner. This time dependent increase is 
also observed with the LAMP1 and LC3 in the graph, which shows LC3 having the greatest 
correlation value of 0.7 at 24 hours. The summary based on the confocal imaging is 
RuS12·AuNP20 co-localises with the lysosomes and autophagosomes in a time dependent 
manner.  
 101 
       
          
 
Figure 32: Pearson’s Coefficient of Correlation value of A549 organelles treated with 0.9nM 
RuS12·AuNP20 at 370C 
The figure shows A549 cells treated with 0.9nM RuS12·AuNP20 for 4, 8, 12, 16 and 24hours 
for each organelle studied. One slide was prepared to represent a time-point and an 
organelle. For each slide, three random images were acquired and the PCC values gotten for 
those images. These values were plotted to quantitatively measure the degree of co-
localization between RuS12·AuNP20 and the organelle. The value shown is the PCC mean 
value of co-localisation ± SEM. Values are from an experiment with no replicate. Organelles 
studied beyond 24 hours were lysosomes and autophagsomes at 24, 48 and 72 hours, their 
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4.2.2. Cellular Localisation by Transmission Electron Microscopy 
Imaging 
TEM imaging was used to study the trafficking and localisation of RuS12·AuNP20 at higher 
resolution, which overcomes the limit of confocal imaging but support the result of confocal 
imaging. A549 cells studied was treated with 0.9 nM RuS12·AuNP20 between 4-72 hours 
similar to confocal imaging study. The result presented shows images at 4, 24 and 48 hours. 
At 4 hours, RuS12·AuNP20 were observed to be localised majorly on the cell membrane 
with evidence of internalization occurring by the protrusion of the cell membrane and 
particularly what appears to be an early endosome (Figure 33b) is observed. This is similar 
to confocal imaging of GFP-RAB4 at 4 hours (Figure 29), where co-localisation with the 
early endosomes (GFP-RAB4) is observed at 4 hours and nanoparticles where localised 
majorly on the membrane. At later time points, TEM images showed more particles are 
internalised as expected and are all localised in vesicles with no evidence of either 
cytoplasmic, golgi, mitochondria or nuclear co-localisation. The representative image at 24 
hours shows interestingly, the co-localisation of RuS12·AuNP20 within the lysosomes 
(Figure 34). The lysosome is identifiable by its high electron density and single membrane. 
Zooming into the lysosomes (Figure 34c), RuS12·AuNP20 is observed to be still mono-
dispersed, spherical, non-aggregated (20 nm) and undigested. The undigested particle 
observed is contrary to what was expected based on the role of the lysosome been the 
digestive organelle of cells. At later time points (48-72 hours), all internalised 
RuS12·AuNP20 were localised in a mix of vesicles. These vesicles were either: multi 
vesicular bodies (MVB), lysosome, and double membrane structure believed to be an 
autophagosome enclosing a lamella body (Figure 35). The result of TEM imaging is in 
agreement with the result of confocal imaging. Consequently, the summary of the 
localisation and trafficking of RuS12·AuNP20 in A549 cells is RuS12·AuNP20 is capable 
of modulating autophagy in A549 cells in a time dependent manner.  
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Figure 33: TEM image of A549 cells treated with 0.9nM RuS12·AuNP20 for 4 hours at  370C 
RuS12·AuNP20 is observed as spherical black dot, which are roughly same size. They are observed to 
be attached to the cell membrane and part of the membrane is found to be disintegrated (green 
arrow).  
a) RuS12·AuNP20 localised majorly on the cell membrane.  
b) RuS12·AuNP20 getting internalised, blue arrow showing a likely early endosomes shown as 
blue circle.  
c) Zoomed in image of a) to show the cell membrane protruding to internalise RuS12·AuNP20 
and forming a likely vesicle shown as red circle.  
Figure 34: TEM image of A549 cells treated with 0.9nM RuS12.AuNP20 for 24 hours at  370C 
a) Most of RuS12.AuNP20 are co-localised in the lysosomes. 
b) Mag of a). to view the lysosome and the lamella body (LB). 
c) RuS12.AuNP20 co-localised in the lysosomes and still mono-dispersed and undigested. 
24hrs a b c 
LB 




Figure 35: TEM image of A549 cells treated with 0.9 nM RuS12·AuNP20 for 48 hours at  370C  
a. wide view  
b. Mag of a 
c. Mag of b showing the perinuclear region and particles all localised in vesicles. 
d-e. No co-localisation within the mitochondria (M) but co-localised in the lysosome (L) and a 
double membrane structures (AV) and one enclosing a lamella body (LB) 
f. Mag of e to show the co-localisation within a double membrane structure containing the 
lamella bodies (LB).  
The experiment was done as a technical duplicate, the images were from a single  
M= Mitochondria, N= Nucleus, AV= Autophagic Vacuole, L= lysosomes, LB= Lamella Body.   
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4.2.3. Western blotting of Microtubule-associated proteins 1A/1B 
light chain 3 (LC3) 
Western blotting was done to detect autophagic vacuoles and this was based on the imaging 
results (confocal and TEM) particularly co-localisation with the LC3 (autophagosomes), it 
appears that RuS12·AuNP20 are trafficked to the autophagosomes and induces autophagy. 
To support this evidence and establish if RuS12·AuNP20 activate the autophagy pathway in 
A549 cells, western blotting of LC3 (autophagy marker light chain 3) protein was conducted 
on A549 cells treated with RuS12·AuNP20 for 2-24 hours (Figure 36). LC3 protein was 
chosen because during the formation of the autophagosomal membrane, cytosolic LC3 
(LC3-I 18 kDa) is conjugated to phosphatidylethanolamine to form LC3-II by lipidation and 
LC3-II becomes associated with active autophagic vesicles. The presence of LC3-II band of 
about 16 kDa indicates the presence of autophagosomes. β-actin (a reference) was used to 
normalise the protein expression in this western blotting and its expression remained 
constant irrespective of treatment. As a positive control, cells were serum starved 24 hours.  
The result showed the control cells (no treatment) and early time points (2-4hours) expressed 
LC3-I (cytosolic form) and later time points of (8-12 hours) expressed LC3-II indicating the 
presence/formation of autophagosomes in a time dependent manner. Therefore, this result 





Figure 36: Detection of LC3 protein by western blotting.  
A549 cells were treated with RuS12·AuNP20 for 2-24 hours (h). Protein was extracted and 
used for detection of lc3 and β-actin. Detection of protein was by chemiluminescent reagent 
and x-ray film exposed for 5minutes. LC3-II is detected at later points, while LC3-1 is 
detected at early time points of 2 and 4 hours, gradually by 8 hours LC3-II is been detected 
all the way to 24 hours.  Positive control used was 24hours serum starved A549 cells. A 
number of trial experiments were done to ascertain the sensitivity of the antibody.  The 
evidence of autophagy was confirmed once and could not be repeated because of lack of 
primary antibody. 
  
+ve C 24h 4h 16h 8h 12h 2h Control 
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4.2.4. Quantitative real-time PCR (RT-PCR) 
With the established link between internalization of RuS12·AuNP20 in A549 and activation 
of autophagy, it is important to begin to understand the mechanism of action of AuNPs. In 
most cases, induction of autophagy is linked to cellular stress, hence the study of genes 
involved in autophagy and oxidative stress. Figure 37 summarises the changes in gene 
expression in the following genes: LC3, heat shock 70kDa protein A (HSP70), glutathione 
reductase (GSR) and catalase (CAT).  The results are expressed as 2e-ΔΔCt, this is fold 
change difference between control and treated samples normalised to a reference gene (β-
actin based on western blot). 
 
Figure 37: RT-PCR of A549 cells treated with 0.9 nM RuS12·AuNP20 over 0-24 hours 
A549 cells was treated with 0.9 nM RuS12·AuNP20 for 0, 4, 16 and 24 hours. At the end of each 
time point, RNA was extracted and reverse transcripted to cDNA. cDNA was used for RT-PCR with 
taqMan gene expression. The experiment is a biological triplicate (n=3) for each time point with 
three technical replicate and presented as mean value ± SEM of fold change compared to control. 
The result showed a statistically significant * (p ≤ 0.05) difference in GSR by one-anova between 












































Surprisingly, HSP remained unchanged between treated and control. LC3 as expected had a 
time-dependent increase in fold change in a time dependent manner. This implies the 
formation of autophagosome over time, further validating the imaging and western blot 
results. CAT shows a 3-fold increase at 4 hours compared to the control, which decreases, 
by half at 24 hours. The GSR gave an interesting result, a 10-fold increase at 4 hours 
compared to the control was observed which decreases over time by 4-fold at 24 hours. 
Based on the results in this chapter, it is evident that RuS12·AuNP20 is modulating 
autophagy via the formation of autophagosomes in a time-dependent manner. However, the 
observed autophagosome induction shows no direct link to stress based on the unchanged 
level in HSP but causes the induction of genes involved in detoxification especially at early 
time points.  
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4.3 Discussion  
The aim of this chapter is to establish the intracellular fate of RuS12·AuNP20 in A549 cells. 
The internalization starts with the protrusion of cell membrane that leads to the 
RuS12·AuNP20 localisation in membrane bound vesicles. This observation is similar to 
other studies on trafficking AuNP in mammalian cells (Chithrani & Chan, 2007; Huang et 
al., 2015b; Jiang et al., 2008; Nativo et al., 2008; Uboldi et al., 2009). From the previous 
chapter on uptake (chapter 3), two routes of internalization of RuS12·AuNP20 in A549 cells 
were suggested to be macropinocytosis and clathrin-mediated endocytosis (clathrin and 
caveolae). Macropinocytosis leads to the formation of a large endocytic vesicles called 
macropinosomes (Panariti et al., 2012). Macropinosomes over time fuses with acidic 
organelles such as lysosome (Hillaireau & Couvreur, 2009). The clathrin-mediated 
endocytosis on the other hand causes an invagination of cell membrane, which pinches off 
and forms a vesicle that becomes an early endosomes (Doherty & McMahon, 2009; 
McMahon & Boucrot, 2011).  
Early endosomes are heterogeneous in terms of morphology, function and localisation 
(Huotari & Helenius, 2011; Lakadamyali et al., 2006). They are small and mostly found 
close to the plasma membrane (Pascua-Maestro et al., 2017). They receive most of their 
cargo from receptor-mediated endocytosis endocytosis (clathrin and caveolin-mediated 
endocytosis), which is highly suggested to be one of the routes of uptake of 
RuS12·AuNP20 into A549 cells (chapter 3). We observed at early time points the first 
endocytic vesicles for internalised RuS12·AuNP20 was the early endosomes evident from 
both confocal (co-localisation with RAB4 Figure 29) and TEM imaging (localisation in 
small vesicles close to the membrane). Early endosomes is the main sorting station of 
internalised AuNP and is identifiable by the time it takes the AuNP to be localised within it 
usually few hours after exposure (Jovic et al., 2010; Maxfield & McGraw, 2004). Therefore, 
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trafficking of RuS12·AuNP20 in A549 cells starts from, the plasma membrane to early 
endosomes. AuNP in the early endosomes can be sorted to one of three possible pathways: 
1. Degradation pathway en route to the lysosome, 
2. Connecting pathway that is delivery to golgi  
3. Recycling pathway (Huotari & Helenius, 2011; Weisz & Rodriguez-Boulan, 2009). 
 Since our result showed RuS12·AuNP20 localised mostly in vesicles located around the 
nucleus and no evidence of golgi co-localisation with golgi (Figure 26), this suggests that 
RuS12·AuNP20 in A549 cells is trafficked to degradation pathway en route to the 
lysosomes. Similarly, AuNP uptake by macropinocytosis are also trafficked to the lysosomes 
and based on our observation at early time points showing protrusion of cell membrane, it is 
implied that internalised RuS12·AuNP20 is trafficked to the lysosome via the endo-
lysosomal pathway. The main function of endo-lysosomal pathway is the bulk degradation 
or recycling of internalised material (Repnik et al., 2013). The endo-lysosomal pathway 
involves the movement of internalised particles via vesicular trafficking until it gets to the 
lysosomes. The early endosome is dynamic and undergoes maturation by luminal 
acidification during endocytic trafficking, to become a late endosome (Hillaireau & 
Couvreur, 2009; Huotari & Helenius, 2011) as depicted in Figure 38. Multi vesicular bodies 
(MVB) are a special type of late endosomes, they are called MVB because they constitute 
of membrane-bound intraluminal vesicles i.e. different vesicles within them (Gruenberg & 
Stenmark, 2004). AuNP en route to the degradative route is trafficked to the late 
endosome/MVB first before the lysosomes. Our evidence that RuS12·AuNP20 is trafficked 
to the lysosomal degradation pathway is supported by our TEM images (Figure 33) that 
shows co-localisation within late endosomes. The late endosomes over time moves to 
perinuclear region and is capable of fusion with a primary lysosomes that originates from 
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the golgi (heterotypic fusion) (Piper & Luzio, 2001). The fusion with the lysosome creates 
a transient hybrid organelle called an endolysosome that matures to become a secondary 
lysosome which is electron dense and can easily be observed by TEM (Luzio et al., 2007).  
 
Figure 38: Intracellular trafficking of ENPS   
A. Macropinocytosis: ENPS are internalised first into the macropinosome, which later fuses 
with lysosomes. B & C. Receptor-mediated endocytosis: ENPS internalization leads to the 
formation of early endosomes, which undergoes maturation and acidification by fusing with 
primary lysosome to become a late endosomes. Image adapted from (Hillaireau & 
Couvreur, 2009). 
 
The late endosome contains lysosomal membrane protein such as LAMP1 (Huotari & 
Helenius, 2011) which is also abundant in the lysosome (Griffiths et al., 1988). Our result 
of LAMP1 co-localisation with RuS12·AuNP20 (Figure 30) which increased over time as 
expected and localisation in electron dense structure further supports the lysosomal 
degradation pathway. The lysosome is the meeting point of all internalised AuNP as the site 
of degradation irrespective of route of uptake (Panariti et al., 2012) and our result is in 
agreement with this.   
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Similar observation with mammalian cells treated with AuNP shows an increase in co-
localisation with acidic compartments or lysosome in a time dependent manner and no co-
localisation with the nucleus, mitochondria, endoplasmic reticulum, or Golgi 
(Brandenberger et al., 2010; Mironava et al., 2010; Wang & Petersen, 2013; Zarska et al., 
2016). Also observed were localisation of RuS12·AuNP20 in lamella bodies of A549 cells. 
Lamella bodies in A549 cells are membrane bound organelles involved in storage and 
secretion of lung surfactant (Mulugeta et al., 2002; Schmitz & Muller, 1991). They contain 
lysosomal enzymes such as LAMP1 and are linked by vesicular exchange to MVB (Wasano 
& Hirakawa, 1994; Weaver et al., 2002), hence the observed localisation of RuS12·AuNP20 
with the lamella body. Due to their link with MVB, they are capable of binding with the 
lysosome (heterotypic fusion) as was observed at later time points of 48 hours (Figure 35). 
Similar observation of localisation of AuNP with the lamella bodies in A549 cells have been 
reported (Wang & Petersen, 2013) as well as other types of ENPs (Schumann et al., 2012) 
in A549 cells. Although, RuS12·AuNP20 is trafficked to the lysosome for degradation, it is 
not degraded in the lysosomes. Similar observation of retention of AuNP in lysosome 
without degradation has been reported in vitro (Kreyling et al., 2015) as well as in vivo which 
gradually degraded after months of internalization (Sadauskas et al., 2009). 
Generally, materials to be degraded are trafficked to the lysosome in two ways: either 
through the late endosomes; usually exogenous materials or autophagosome; usually 
endogenous materials (Eskelinen & Saftig, 2009; Liou et al., 1997). Autophagosomes are 
double membrane vesicles that are formed around intracellular substrate such as part of the 
cytoplasm or organelles in a non-specific manner and targets its content for lysosomal 
degradation by lysosomal hydrolases in a process called autophagy as depicted in Figure 39 




Figure 39: Process of Autophagy 
Autophagosomes are formed from a phagophore/isolation membrane sequestering part of 
cytoplasm or organelles. Autophagosomes can subsequently fuse with the endosome or lysosome 
to form amphisome or autolysosome. In TEM imaging, it is difficult to distinguish between 
autophagosome, amphisome or autolysosome, so they are collectively referred to autophagic 
vacuole. Images adapted from (Mizushima, 2007).    
 
 
The formation of autophagosomes causes it to receive lysosomal constituents such as 
lysosomal membrane proteins (LAMP1) either by fusing with late endosomes and forming 
an amphisome or fusing with a lysosome and forming an autolysosomes (Eskelinen, 2005; 
Eskelinen & Saftig, 2009). Autophagosomes, amphisome and autolysosomes are 
collectively referred to as a autophagic vacuoles and are very similar in their structure and 
function (Mizushima, 2007). Lysosomal enzymes degrade contents of both amphisome and 
autolysosomes. Autophagy and endo-lysosomal pathway both converges at the lysosomes 
for degradation as well (Gordon & Seglen, 1988; Hoyvik et al., 1987; Liou et al., 1997; Yi 
& Tang, 1999). This also explains the increasing co-localisation over time of 
RuS12·AuNP20 with LAMP1 (Figure 30). The result in Figure 35e shows RuS12·AuNP20 
co-localisation in a double membrane structure that either has an organelle or part of a 
cytoplasm, these characteristic are synonymous with autophagosomes/autophagic vacuoles 
and this co-localisation is observed at later time points. 
Further supporting the evidence of formation of autophagosomes are the increasing co-
localisation of RuS12·AuNP20 with GFP-LC3 (Figure 31) which also increases over time 
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as well as the western blot of LC3-II protein (Figure 36) which shows formation of 
autophagosomes over time because LC3-II is localised on autophagosomes and 
autolysosomes. Various ENPs including AuNP have been reported to induce 
autophagosomes accumulation. They are viewed as autophagy activators, which can be 
further harnessed for its therapeutic potential by inducing autophagy as a treatment in some 
metabolic diseases (Huang et al., 2015a; Li et al., 2010; Ma et al., 2011; Peynshaert et al., 
2014; Stern et al., 2012; Wei et al., 2010; Zabirnyk et al., 2007). Autophagy activation by 
AuNP is a means of degradation of particles since it involves the lysosome, while ensuring 
cell survival. However, RuS12·AuNP20 was not degraded. Ma et al. (2011) observed AuNP 
altered autophagic activity by impairment of lysosomes degradation activity, which caused 
lysosomal enlargement and alkalinisation, resulting in accumulation of autophagosomes and 
upregulation of LC3-II, which is similar to our RT- PCR result of LC3 protein. This helps 
explains a plausible reason for the observed intact RuS12·AuNP20 in autophagic vacuoles 
even at 72 hours. Interestingly, they attributed their observation of accumulated 
autophagosomes to a blockage of autophagy rather an activation of autophagy. Autophagy 
occurs at a basal level when there is a surplus supply of nutrient (autophagosomes are quickly 
turned over by lysosomes, so no autophagosome accumulation is observed) or under stress 
condition such as starvation which causes accumulation of autophagosomes (Codogno & 
Meijer, 2005; Degenhardt et al., 2006; Ma et al., 2011). Based on this, Ma et al. (2011) does 
not attribute their observation of autophagosome accumulation to stress, although oxidative 
stress is linked to the triggering of autophagy after exposure to AuNP (Ding et al., 2014; Li 
et al., 2010).  
We hypothesize based on our result that the accumulation of autophagosome could be 
because of cellular stress; hence, the measurement in changes in gene expression on stress 
related genes by RT-PCR. The result of HSP 70 expression remaining almost constant is 
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similar to Hauck et al. (2008) that showed no significant up or down regulation changes in 
HSP 70 after exposure to AuNP or silica nanoparticles (Petrache Voicu et al., 2015). This 
observation is opposite to what we expected, because HSPs especially HSP 27 and HSP 70 
are induced on exposure to cellular and oxidative stress to resist subsequent cellular damage 
(Fulda et al., 2010; Samali & Orrenius, 1998). This suggests that stress might not be directly 
linked to the modulation of autophagy observed. Interestingly, an elevated level of CAT and 
GSR observed especially at early time point of 4 hours is an indication of response to either 
ROS/hydrogen peroxide or cellular oxidant detoxification. CAT converts ROS (hydrogen 
peroxide) to water. An enzyme not studied glutathione peroxidase reduce lipid 
hydroperoxides to their corresponding alcohol and reduces free hydrogen peroxide to water, 
while GSR reduces oxidised glutathione (product of glutathione peroxidase) to glutathione. 
CAT and GSR are enzymatic antioxidant defensive mechanism of the cells (Birben et al., 
2012). We propose A549 cells perceives RuS12·AuNP20 especially at an early time point 
as a xenobiotic and causes significant induction of these genes to defend itself as an adaptive 
measure rather than an adverse measure which on more internalization reduces the induction 
of these genes.  
This chapter has studied in details the trafficking of RuS12·AuNP20 from the cell membrane 
to autophagic vacuoles, which appears to be the last vesicles of localisation of particle and 
has proven the involvement of autophagy as a cellular fate of RuS12·AuNP20 in A549 cells. 
In addition, A549 cells strongly perceives RuS12·AuNP20 as foreign once it is beginning to 
get internalised and sets up a defensive/adaptive mechanism which decreases over time but 
does not cause a change in heat shock proteins. Therefore, autophagy is likely not mediated 
by stress but the presence of RuS12·AuNP20. In the next chapter, a proposed mechanism of 








5.1. Introduction  
Quantification of cellular functions usually forms the basis for cytotoxicity testing. 
Examples of such cellular functions include; cell adhesion, membrane integrity, DNA 
stability and metabolic enzyme activities. Using these endpoints, various assays have been 
developed to measure their changes as a way of assessing cytotoxicity (Hussain et al., 2005).  
Cytotoxicity of RuS12·AuNP20 on A549 cells was measured by two different method 
because more than one assay is more informative in determining nanoparticle toxicity 
(Monteiro-Riviere et al., 2009). Cytotoxicity was determined by using two colorimetric 
assays that involves the measurement of absorbance at 590 nm. First assay was MTT assay, 
which is a widely used endpoint for toxicity testing including nanoparticles because of its 
ease of performance and reproducibility (Kroll et al., 2009; Marquis et al., 2009). Second 
assay was CVS assay, which quantifies cell viability based on detachment of adherent cells 
from the culture flask. The principle behind the MTT is: viable cells with active 
mitochondria reduce MTT into a purple coloured formazan with an absorbance of around 
570 nm (Riss et al., 2004). While, the principle behind CVS for cytotoxicity testing is that, 
adherent cells detach from cell culture plates during cell death while staining the remaining 
cells and can be used as an indirect qualification of cell death as well as proliferation 
(Feoktistova et al., 2016). Therefore, a reduction of values in absorbance in both assays 
means a decrease in cell viability. In this current study, these colorimetric methods of cell 
viability was used on A549 cells treated with various concentrations of RuS12·AuNP20 up 
to 72 hours.  
Another indicator of cell viability is the changes in levels of protective factors within the 
cells; an example of such is glutathione. Glutathione is a small intracellular protein thiol 
molecule in the cell, which prevent cellular damage by scavenging ROS (Dickinson & 
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Forman, 2002). In healthy cells, most of glutathione present is in its reduced form (GSH); a 
major cellular antioxidant. In the presence of ROS, GSH is oxidised to GSSG and an 
increasing ratio of GSSG to GSH is an indication of oxidative stress and the health of the 
cells (Birben et al., 2012). Also, the presence of ROS in the cell, can damage the DNA  (Fang 
et al., 2015; Green et al., 2006; Jena, 2012) and damage to DNA such as strand breaks can 
be detected by comet Assay (Collins, 2004). The comet assay is a sensitive and quantitative 
technique for detecting DNA strand breaks in eukaryotic cells. Therefore, the measurement 
of ROS, glutathione and DNA strand break is essential in understanding the cytotoxicity 
potential of RuS12·AuNP20 on A549 cells.  
All cytotoxicity assay was done on A549 cells treated with 0.9 nM of RuS12·AuNP20 
serially diluted to 0.45, 0.225 and 0.1123 nM and incubated for 24, 48 and 72 hours and this 
data was used to establish a non-cytotoxic concentrations and time-points of treatment of 
cells for the uptake and cellular fate described in chapters 3 and 4. Assays were all done as 
biological triplicate with technical triplicate.  
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5.2. Results  
5.2.1. MTT Assay. 
The result presented in Figure 40 is the cytotoxic potential based on mitochondria activity 
of A549 cells treated with RuS12·AuNP20 for 24, 48 and 72 hours. A decrease in absorbance 
is directly proportional to a decrease in cell viability, which is an indication of cells with 
inactive mitochondria. The positive control used was 0.15% (v/v) Triton X-100 with media, 
which resulted in about 90% cell death (shown in appendix 5A). The result shows no 
statistical difference (P ≤ 0.05) between treated and the control cells irrespective of length 
of exposure to particle or the concentration used. However, at 24 and 48 hours, a non-
significant trend in decrease of about 10% in cell viability was observed following treatment 
of A549 cells with increasing concentration of particles. Although not significantly different 
RuS12·AuNP20 may be marginally toxic in A549 cells under these conditions. Overall this 
result suggests that although RuS12·AuNP20 at a concentration of 0.9 nM had no significant 
cytotoxic effect based on MTT assay on A549 cells even up to 72 hours exposure (98% cell 




Figure 40: MTT Assay on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours   
A549 cells was seeded at a density of 8,000 cells per well in 96 well plate and treated with 
RuS12·AuNP20 for 24,48 and 72 hours. At the end of each time points, spent media was replaced with 
media containing MTT for 3 hours, and absorbance read at 590 nm was used to calculate cell viability. 
The experiment is a biological triplicate (n=3) and presented as % control of mean value ± SEM. The 
result showed no statistically significant (p≤0.05) difference by one-anova and Bonferroni Post Hoc 
analysis between treated and control cells irrespective of length of exposure  
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5.2.2. Crystal Violet Assay.  
The measurement of cytotoxic potential of RuS12·AuNP20 treated with A549 cells up for 
24, 48 and 72 hours as assessed by the crystal violet assay is presented in Figure 41. The 
positive control used was 0.15% (v/v) Triton X-100 with media, which resulted in about 
60% cell death (shown in appendix 5B). Cells treated with RuS12·AuNP20 for 24 hours, 
irrespective of concentration, showed a statistically significant (P ≤ 0.05) decrease in cell 
viability of about 20% when compared to the untreated control. This significant decrease 
was not observed at later time points of 48 and 72 hours. Overall, this result suggests that 







Figure 41: CVS on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours   
A549 cells was seeded at a density of 15,000 cells per well in 24 well plate and treated with RuS12·AuNP20 
for 24, 48 and 72 hours.  At the end of each time point, cells were stained with 1% crystal violet solution 
for 30 minutes and absorbance was read at 590nm. The experiment is a biological triplicate (n=3) and 
presented as % control of mean value ± SEM. The result showed a statistically significant *(p ≤ 0.05) 
difference by one-anova and Bonferroni Post Hoc analysis between treated and non-treated control at 
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5.2.3. Dichloro-dihydro-fluorescein diacetate (H2DCFDA Assay)  
The level of ROS in A549 cells treated with RuS12·AuNP20 for 24, 48 and 72 hours was 
assessed by the oxidation of H2DCFDA to fluorescent DCF is presented in  
 
Figure 42. A549 cells treated with hydrogen peroxide (200 µm) were used as positive control 
and showed 60% increase in fluorescence intensity (data shown in appendix 5C). No 
statistically significant difference was observed between the fluorescence intensity of treated 
cells and non-treated control up to 72 hours period irrespective of concentration of 
RuS12·AuNP20 used. An observable trend was a time dependent increase. Overall, this 
result suggests that the production of ROS in A549 cells treated with RuS12·AuNP20 is not 






Figure 42: DCFH-DA Assay on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours   
A549 cells were seeded at a density of 8,000 cells per well in a white-wall clear bottom 96 well plate and 
treated with RuS12·AuNP20 for 24, 48 and 72 hours. At the end of each time point, spent media was 
replaced with media containing DCFH-DA for 45 mins and fluorescence intensity was read at λexc= 485nm 
and λem =545nm. The experiment is a biological triplicate (n=3) and presented as % control of mean value 
± SEM. The result showed an increasing trend in a concentration and time-dependent manner that 
leads to ROS generation but this was not statistically significant by one-anova and Bonferroni Post 
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5.2.4. Glutathione Assay 
The levels of reduced glutathione (GSH) in A549 cells treated with RuS12·AuNP20 was 
quantified over 24-72 hours and the result is presented in Figure 43 (Representative GSH 
standard curves are shown in the appendix 5D1).  A decrease in reduced glutathione level 
would be consistent with the occurrence of oxidative stress. A549 cells treated with 
hydrogen peroxide (200 µm) was used as positive control and a 50% difference decrease of 
glutathione is observed when compared to the non-treated control (shown in appendix 5D2). 
Generally, a time-dependent decrease in glutathione levels was observed irrespective of 
concentrations following treatment with RuS12·AuNP20 when compared to the non-treated 
control.  However, this was only statistically significant (P ≤ 0.05) following treatment with 
0.9 nM and 0.45 nM of RuS12·AuNP20 and 0.9 nM of RuS12·AuNP20 at 72 and 48 hours 
respectively. This result indicates that treatment with RuS12·AuNP20 causes reduced GSH 




Figure 43: GSH Assay on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours   
A549 cells were seeded at a density of 100,000 cells per well in 6 well plate and treated with RuS12·AuNP20 
for 24, 48 and 72 hours. At the end of each time point, protein was precipitated by TCA, and fluorescence 
intensity was read at λexc= 350nm and λemi=520nm. The experiment is a biological triplicate (n=3) and 
presented as % control of mean value ± SEM. The result showed a statistically significant * (p ≤ 0.05) 
difference by one-anova between treated and control cells at 72 and 48 hours at highest concentrations 





































5.2.5. Alkaline Comet Assay  
Cells used for comet assay are embedded in agarose gel and are first lysed to reveal the 
nucleoid containing negative supercoiled DNA, which then undergo electrophoresis. 
Electrophoresis causes an unwinding of the DNA, only unwound  DNA with strand breaks 
would migrate to the anode resulting in a comet-like structure; i.e. the comet ‘head’ which 
is undamaged and the tail which is damaged DNA  (Zainol et al., 2009). Representative 
images illustrating the alkaline comet are shown in Figure 44A-D. Figure 44A shows control 
cell (untreated A549 cells) with minimal damage. While Figure 44 B shows A549 cells 
treated with 200 µm of hydrogen peroxide (positive control) for 1 hour, all cells have 
extreme unwinds indicating the formation of DNA-strand break. Figure 44 C and D are A549 
cells treated with 0.225 and 0.9 nM of RuS12·AuNP20 respectively for 24 hours. The result 
presented in Figure 45 is mean of the median tail intensity, against the conventional mean of 
mean of tail length. This is so because the measurement of the damage is often not normally 






















After 24-hour treatment of A549 cells with RuS12·AuNP20, a concentration dependent 
increase in median tail intensity was observed, which was statistically significant (P ≤ 0.05) 
at the highest concentration of 0.9 nM when compared to untreated control. Although, an 
increase of 123% and 134% was observed at later time points of 48 and 72 hours respectively 
when compared to the control, these differences were not statistically significant.   
Figure 44: Representative images of cell nuclei of A549 assessed for DNA strand break by Comet 
Assay.  Arrows indicate comet-like structure.  
A. Control A549 cells. 
B. Positively treated cells; 200 µm of hydrogen peroxide for 1 hour 



























Figure 45: Median Tail intensity of A549 cells treated with RuS12·AuNP20 
A549 cells were seeded at a density of 200,000 cells per well in six well plate and treated with 
RuS12·AuNP20 for 24, 48 and 72 hours. At the end of each time point. Cell suspension was used to 
prepare slides for comet assay. The experiment is a biological triplicate and presented as % control of 
mean value ± SEM. The result showed a statistically significant * (p ≤0.05) difference by one-anova 
and Bonferroni Post Hoc analysis between treated and non-treated control cells at 24 hours at highest 
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5.3 Discussion  
The study of the toxic potential of AuNP to cell is important in it safety assessment. 
Previous studies have reported contradictory findings about their toxicity in vitro (Murphy 
et al., 2008; Nel et al., 2006; Pan et al., 2009). Previous published data from our lab with 
same functionalised AuNPs demonstrated that at concentrations up to 0.9 nM, particles are 
not toxic after 24 hour treatments  (Rogers et al., 2014). This chapter aimed to establish the 
cytotoxic effect of internalised RuS12·AuNP20 in A549 cells following longer treatment 
up to 72 hours.  
Cells in culture that undergo cell death lose their adherence properties which is measured 
by CVS, CVS can be comprised by proliferative response that occur at the same time as 
cell death response (Feoktistova et al., 2016). Therefore, it is important that the data is 
validated using an additional independent method to asses cell viability. The MTT is an 
enzymatic assay that relies on capacity of succinate dehydrogenase, a mitochondrial 
dehydrogenase to reduce the tetrazolium salt to a formazan in the mitochondria (Slater et 
al., 1963). Asides the mitochondria, the reduction of tetrazolium salt has been reported to 
occur in other places such as cytoplasm, surface of non-mitochondria membrane 
(endosome/lysosome) and the plasma membrane (Berridge et al., 2005; Sliwka et al., 
2016).   
Our MTT data showed RuS12·AuNP20 had no statistically significant effect on  the 
viability of A549 cells, which is similar to previous studies on AuNPs in A549 cell (Rogers 
et al., 2014), other cancer cell lines (Connor et al., 2005) but contradictory to some previous 
studies in A549 cells (Patra et al., 2007; Uboldi et al., 2009). Interestingly, CVS showed a 
significant decrease in cell viability only after 24 hours treatment similar to the MTT 
(decrease in cell viability at 24 hours) although not significant. Taken together, both assays 
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suggests that the effect of RuS12·AuNP20 on A549 on cell viability is greatest at 24 hours 
compared to later time points of 48 and 72 hours and furthermore RuS12·AuNP20 does 
not inhibit the growth of A549 cells.  
In contrast, Uboldi et al. (2009) found that citrate coated AuNPs were toxic to A549 cells 
treated for similar times (24, 48 and 72 hours) at 0.7 mM. They attributed the observed 
decrease in cell viability to the presence of contaminants such as excess sodium citrate used 
during the synthesis of AuNP and suggested dialysed and purified AuNP would be less 
cytotoxic. The free ruthenium complex on RuS12·AuNP20 is non-toxic in A549 cells by 
MTT (appendix data 5A2) and RuS12·AuNP20 is purified by size exclusion before treating 
with cells. This purification step could help explain the lack of toxicity observed by MTT 
in this current study. It has been reported that MTT assay is not capable of differentiating 
between dead cells and dormant or inactive cells (Berridge et al., 2005). In contrast, most 
researchers agrees that CVS stains only live cells, which is attributed to the measurement 
of DNA mass of viable cells (Sliwka et al., 2016) implying that the observed cell viability 
by CVS could be more reliable than cell viability by MTT. Further evidence to back up the 
lack of toxicity observed by MTT was suggested by Hauck et al. (2008). They attributed 
lack of toxicity of AuNP to its localisation in membrane bound vesicles, making the 
particles directly unavailable to nuclei and other organelles such as mitochondria. This 
suggestion was evident in this study where RuS12·AuNP20 were localised in endocytic 
vesicles (chapter 3 and 4) with no evidence of nuclei or mitochondria localisation and lack 
of toxicity by MTT.  
Cellular internalization of AuNP has been linked to oxidative stress as reviewed above. 
Oxidative stress is the result of the disruption to the balance of oxidant and anti-oxidant 
levels in the cells. Most oxidant results from the increased production of ROS causing a 
depletion of antioxidant to detoxify the ROS (Manke et al., 2013). In this current study, 
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only a slight non-significant increase in ROS production in A549 cells was observed , 
which is in agreement with Fan et al. (2012). This is in contrast with other studies that has 
shown significant increase in ROS production in cells treated with AuNPs (Dayem et al., 
2017; Li et al., 2008; Pan et al., 2009; Zhang et al., 2013). ROS production has been linked 
to damage/localisation in mitochondria (Wang et al., 2011) and/or ER stress (Tsai et al., 
2011) which was not observed in this study (no-localisation in mitochondria or ER). 
Mitochondria is the major intrinsic source of intracellular ROS generation via the electron 
transport chain. The lumen of the ER. is a suitable oxidizing environment (high ratio of 
oxidised-to-reduced forms of GSH) for protein folding and formation of disulphide bonds 
(Van Der Vlies et al., 2003). For this reason, localisation of particles within these two 
organelles (mitochondria and ER) contributes to increase production of ROS. As 
established in chapter 4, RuS12·AuNP20 do not localise within the mitochondria or the ER 
of A549 cells, hence a likely reason for an insignificant effect on the production of ROS 
even up to 72 hours.  
Asides, oxidative stress, AuNP internalization has been linked to DNA damage 
(Chompoosor et al., 2010; Li et al., 2010; Manke et al., 2013; Pan et al., 2009). Although 
there was no significant increase in the level of ROS as assessed by H2DCFDA assay, there 
was evidence of redox changes in A549 cells following treatment with RuS12·AuNP20. 
The significantly decreased level of GSH observed at later time points (48 and 72 hours) 
in a concentration dependent manner. This is similar to a number of studies that showed 
depletion of GSH in cells following AuNP treatment (Chen & Chang, 2004; Gao et al., 
2011). Therefore, following treatment of A549 cells with RuS12·AuNP20, the possibility 
of oxidative stress occurring exist. Interference of nanoparticles or the components of 
nanoparticles such as thiols with H2DCF assay have been reported to either enhance or 
quench fluorescence signals leading to inaccurate measurement of generated ROS (Huang 
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et al., 2005; Kroll et al., 2012; Roesslein et al., 2013). This observation could be a plausible 
reason for the observed ROS data by H2DCF assay. Tan et al. (1998) concluded that GSH 
depletion should not only be linked to ROS production, but other factors such as protease 
activation and Ca2+ mobilization should be studied before concluding ROS production 
leads to cytotoxicity.  
In addition to depleted GSH levels observed, comet assays showed a positive result for 
DNA damage by strand breaks and similar observation has been made in other studies 
(George et al., 2017; Li et al., 2011). The DNA strand break was statistically significant at 
highest concentration of 0.9 nM at 24 hours (although there was an increase at other time 
points) which corresponds to the decreased cell viability by CVS and MTT at 24 hours. 
This observation is interesting because CVS measurement is based on DNA mass, and if 
DNA undergoes a significant amount of DNA damage, this possibly explains the 
correlation in results of comet assay and cell viability especially at 24 hours. It is 
interesting, that cell viability and DNA strand break effects in contrast to GSH depletion 
and increased ROS production effect in A549 cells treated with RuS12·AuNP20 is 
pronounced at 24 hours compared to later time points of 48-72 hours. An explanation of 
this observation is the ability of cells to adapt to stress following treatment. For example 
by inducing the synthesis of GSH as an adaptive response to internalised ENPs (Neibert & 
Maysinger, 2012) and this was evident from the RT-PCR result that showed a marked 
increase in glutathione reductase discussed in chapter 4. A possibility for the reduction of 
GSH level over time may be attributed to the ability of the particle binding to GSH. This 
is feasible because GSH is a thiol compounds and is capable of binding to metallic 
nanoparticles (Tauran et al., 2013).  
It is unclear how RuS12·AuNP20 can cause DNA damage in A549 cells, as it showed zero 
co-localisation with the nucleus evident from TEM images in chapter 3 and 4. An indirect 
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mechanism of DNA damage proposed irrespective of localisation in membrane bound 
structure could be from a nonspecific interaction with proteins leading to abnormal protein 
production (Li et al., 2008; Pernodet et al., 2006).   
This chapter has demonstrated that RuS12·AuNP20 treatment in A549 cells is capable of 
inducing slight toxicity at 24 hours, which does not inhibit cell growth even up to 72 hours, 
and the formation of ROS was not statistically significant as assessed by H2DCFDA. In 
contrast to GSH depletion and DNA damage after prolonged period of treatment. An 
indirect interaction of particles with proteins is suggested as a means of oxidative stress 
and DNA damage, which is subject to further investigation. In a recent study by George et 
al. (2017), they reported that AuNP is capable of interfering with comet assay to generate 
overestimated false positive they recommend additional genotoxicity testing such as 
micronucleus and chromosomal aberration before making definite claim about the 
genotoxicity of AuNPs. Additional work investigating the cytotoxicity of RuS12·AuNP20 
in A549 cells is recommended, as this would enable a more detailed understanding of the 










6.1. General Discussion  
ENPs especially metallic nanoparticles and specifically AuNP has been extensively 
reviewed at the beginning of this thesis with an emphasis on their bio-medical importance 
as diagnostic and therapeutic agents. The unique characteristic of AuNP particularly their 
SPR is heavily exploited during their synthesis and design of functionalised AuNP with 
biomedical application aimed to be clinically translated. This therefore led to the design of 
functionalised AuNP used in this thesis; RuS12·AuNP20 a functionalised AuNP with 
ruthenium bipyridine SS (a luminescent transition metal complex) which has great potential 
as a nanoprobe. Nanoprobes can be used as contrast agents during imaging and as drug 
delivery vehicles for targeted therapeutics (Panchapakesan et al., 2011). This thesis focused 
and has presented an extensive in vitro cellular study of RuS12·AuNP20 in A549 cells by 
trying to elucidate the mechanism of uptake, trafficking the particles to determine their sub-
cellular localisation and cellular fate and lastly their mechanism of toxicity. The 
characterization of RuS12·AuNP20 was done first to ascertain the physiochemical properties 
of the particles before any cellular studies, which was done between 2-72 hours after 
exposure to nanoparticles. The characterization result of particles showed RuS12·AuNP20 
to be 20 nm in size, spherical in shape and have an emission peak at the red channel 
wavelength. A non-toxic concentration of 0.9 nM in A549 cells was obtained by MTT assay 
after 72 hours exposure and used for cellular study.  
The cellular uptake of RuS12·AuNP20 in A549 increased in a time dependent manner, 
evident from both imaging (confocal and TEM) and analytically result by ICP-MS. TEM 
imaging enables visualisation of individual particles which can then be monitored over time 
but labour intensive when it comes to be quantification, which led to the use of ICP-MS and 
developing a method to quantify the images acquired form confocal microscopy. 
Quantification of cellular uptake by both technique confirmed the time dependent increase, 
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which has been similarly observed in other in vitro study where functionalised AuNP cellular 
uptake increased over time (Chithrani et al., 2006; Huefner et al., 2014; Patra et al., 2007; 
Xie et al., 2017). Both imaging method showed the particles to be localised majorly on the 
cell membrane and ruffling of the cell membrane at early time between 2-4 hours after 
treatment indicating the start of internalization by endocytosis. Endocytosis is an established 
mechanism of cellular uptake of AuNP that involves either the membrane protruding or 
invagination to engulf particles leaving the particles trapped in vesicles (Levy et al., 2010). 
Although we were unable to directly prove the type of endocytosis involved, we present 
strong evidence that macropinocytosis and clathrin-mediated endocytosis were the major 
routes of cellular uptake. Those evidence were from the TEM imaging (Figure 19 and 20). 
The possibility of having two forms of endocytosis has been reported (Brandenberger et al., 
2010; Yang et al., 2013) and interestingly they both reported the involvement of both 
macropinocytosis and clathrin-mediated endocytosis and the localisation of AuNP in 
vesicles which is similar to our observation of localisation in vesicles in perinuclear region.  
To identify these vesicles, RuS12·AuNP20 were trafficked and cellular fate monitored. 
Trafficking of RuS12·AuNP20 was achieved by co-localisation study of organelles involved 
in the endocytic pathway either by using molecular probe or transiently by transfecting A549 
cells to express organelle specific markers. Co-localisation was quantified by measuring the 
Pearson coefficient of correlation (PCC) between RuS12·AuNP20 (red) and organelle of 
interest (green) and the closer the value is to 1, the higher the co-localisation. The trafficking 
results showed no co-localisation of RuS12·AuNP20 within the golgi, endoplasmic 
reticulum and mitochondria with their PCC values all below 0.3. Co-localisation of 
RuS12·AuNP20 was observed with the early endosomes at early time points and a time 
dependent increase in co-localisation within the lysosomes and autophagosomes was 
observed with PCC values of 0.7. The organelles that demonstrated co-localisation: early 
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endosomes, lysosomes and autophagosomes are all involved in the endo-lysosomal pathway, 
which is a degradative pathway via the lysosome irrespective of type of endocytosis (Stern 
et al., 2012). Our result of time dependent increase in co-localisation in the endo-lysosomal 
pathway is summarised in table 5 and is consistent with similar studies that have observed 
co-localisation of functionalised AuNP with lysosomes and other acidic organelles in an 
increasing time dependent manner (Mironava et al., 2010; Wang & Petersen, 2013; Zarska 
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Table 5: Summary of the trafficking of RuS12·AuNP20 in A549 cell from 2-72hrs.  
Based on imaging results, RuS12·AuNP20 once internalised is localised within the lysosome and 
autophagosome, in a time dependent manner. CM; confocal imaging, TEM; transmission electron 
microscopy.  
 
One unanticipated findings was the intactness of RuS12·AuNP20 within the lysosomes 
because the role of the lysosome is degradation usually via autophagy and the main function 
of endo-lysosomal pathway is bulk degradation of internalised materials (Panariti et al., 
2012; Repnik et al., 2013). Autophagosomes are autophagic vacuoles involved in autophagy. 
The presence of autophagosomes at later time points and increase in gene expression of LC3 
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proteins on the inner membrane of autophagosomes indicates the involvement of autophagy 
as a cellular fate of RuS12·AuNP20 in A549 cells. Autophagy activation has been reported 
on exposure to AuNP (Li et al., 2010; Zabirnyk et al., 2007). However, in our case there is 
a possibility that RuS12·AuNP20 is altering the degradation activity of the lysosome, which 
then alters autophagy and prevents RuS12·AuNP20 degradation. The rationale behind this 
possibility is justified by a study that showed internalization of AuNP and co-localisation 
within the lysosome caused alkalinisation of the lysosome resulting in lysosomal impairment 
yet upregulating gene expression of LC3-II indicating co-localisation in autophagosomes 
(Ma et al., 2011). Interestingly, this study suggested a blockage of autophagy rather than an 
activation of autophagy as a basis of observed increased autophagosomes, which could be a 
similar occurrence in this study.  
Having established that RuS12·AuNP20 modulates autophagy, we investigated if the 
internalization of RuS12·AuNP20 in A549 results in cellular stress, because stress is a 
known activator of autophagy (Li et al., 2010) and AuNP mechanism of toxicity is 
potentially via production of ROS which leads to oxidative stress (Alkilany & Murphy, 
2010). Although there was no change in gene expression of HSP (stress related gene), there 
was a marked increase in CAT and GSR at early time points of 4 hours which is when active 
cellular uptake was observed as membrane ruffling. The GSR results suggests an increase in 
the conversion of oxidised glutathione to reduced glutathione (GSH) to maintain the level of 
cellular GSH a major antioxidant involved in cell protection and neutralization of free 
radicals especially ROS (Gao et al., 2011). Similar to GSR, CAT protects the cells from 
oxidative stress caused by ROS. Interestingly, over time the GSR and CAT gene expression 
reduced, this observation is probably due to an adaptive mechanism by A549 cells by 
producing CAT and GSR, which upon more internalization over time causes a reduction of 
CAT, and GSR. Interestingly, the ROS data showed no significant production of ROS even 
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up to 72 hours but showed a significant depletion of GSH enzyme at 72 hours likely due to 
the more internalised RuS12·AuNP20 and also observed is a significant increase in DNA 
single strand break by comet assay at 24 hours, which reduced over time. The depleted GSH 
is an indication of oxidative stress majorly linked to over-production of ROS.  
The production of ROS is usually associated with co-localisation within the mitochondria, 
ER or nucleus (Tsai et al., 2011; Wang et al., 2011), which was absence in this study. 
However, pathways and processes involving ROS such as DNA damage, increased CAT and 
GSR, depleted GSH all observed is suggestive of an indirect mechanism of toxicity of 
RuS12·AuNP20 in A549 cells that does not involve co-localisation within these organelles. 
Although by MTT assay, RuS12·AuNP20 showed no toxicity, but unexpectedly the cell 
viability measured by CVS decreased significantly at 24 hours. This outcome might be 
attributed to MTT assay measuring mitochondria activity while CVS recognises viable cells 
by measurement of DNA mass (Berridge et al., 2005; Sliwka et al., 2016) and because 
RuS12·AuNP20 showed no co-localisation within the mitochondria, so it is expected for 
MTT result to show no significant difference in cell viability. However, the result of the 
comet assay and CVS are similar because they both that have to do with measurement of 
DNA although RuS12·AuNP20 showed no evidence of nuclear localisation further affirming 
the evidence of an indirect mechanism of toxicity. Table 7 shows a summary of data 






 24 hours 48 hours 72 hours 
MTT Assay - - - 





H2DCFDA Assay - - - 
Glutathione Assay - 0.45 nM* 0.45 nM* 
0.9 nM* 
Comet Assay 0.9 nM* - - 
 
B.  
 Control 4 hours  16 hours 24 hours  Summary Note  
LC3 1 1.5 2.0 2.2 Slight increase 
compared to the 
control. 
HSP70 1 1 1 1 No change in gene 
expression  
CAT 1 3.1 2.7 2.6 Increase in treated 
which decreases over 
time  
GSR 1 11 7.3 6.0 Significant increase at 
early time point, which 
decreases over time.  
Table 6: Summary of intracellular fate and toxicity of A549 treated with RuS12·AuNP20 
a. Summary of toxicity data showing treatment with different concentrations at various  
time points. Only statistically significant (*) treatment compared to the control was 
shown. At 24 hours, crystal violet assay and comet assay showed statistical significant 
difference between the treated and controlled. At later time points, glutathione assay 
showed a decreased in glutathione level.  
b. Summary of changes in gene expressions of genes tested at various time points 
compared to the control. All experiment were done with the same concentration of 
0.9nM of RuS12·AuNP20. The GSR and CAT showed increase at early time points, which 
decreased over time.  
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6.2 Conclusion  
This thesis has demonstrated and proven the cellular uptake of RuS12·AuNP20 in A549 
cells.  The cellular uptake was quantified using image quantification of acquired confocal 
images and analytically by ICP-MS. Both methods showed a similar trend of increase over 
time in cellular uptake. Also established is that the cellular uptake occurs by endocytosis 
specifically macropinocytosis and clathrin–mediated endocytosis evident form TEM 
imaging. The endocytosis increased in a time dependent manner and RuS12·AuNP20 were 
solely localised in vesicles with no evidence of nuclear or cytoplasmic co-localisation. The 
trafficking of RuS12·AuNP20 over the period of 2-72 hours identified the endo-lysosomal 
pathway as the route of internalisation. This pathway led to a final co-localisation within 
lysosome and/or autophagic vesicles, which was found to modulate autophagy. Modulation 
of autophagy was evident from the accumulation of autophagosomes. Finally, 
RuS12·AuNP20 is probable of causing toxicity by an indirect mechanism of action with 
DNA to cause single strand break and depletion of GSH over time. Overall RuS12·AuNP20 
has proven to be a stable intracellular nanoprobe in A549 cells as it does not show any 
evidence of degradation or losing it luminescence however, RuS12·AuNP20 modulates 




6.3 Future Work/ Recommendations 
This study has shown with imaging evidence macropinocytosis and clathrin-mediated 
endocytosis is involved in the cellular uptake of RuS12·AuNP20 in A549 cells but without 
direct confirmation. To confirm the exact mechanism of cellular uptake without the use of 
endocytic inhibitors, it would be better to study the signalling pathways involved in this 
process possibly by monitoring changes in gene expression of actin and other proteins such 
as EGFR15 present in clathrin-coated pits.  
To confirm if RuS12·AuNP20 co-localisation at later time points in the lysosome is causing 
an increase in pH; cells could be treated with substances known to alkalinise the lysosome 
and compare it with cells treated with nanoparticle. This would help understand why 
RuS12·AuNP20 is not degraded in the lysosome. To fully understand the cellular fate of 
RuS12·AuNP20 in A549 cells, a study of the possibility of exocytosis would be an advantage 
because exocytosis of AuNP has not been documented as much as endocytosis. It could be 
done by splitting the cells after 72 hours exposure and seeding them without exposure to any 
particles but imaging the cells over the next 72 hours to see if the particles are still 
internalized.  
Finally, because of the marked increase in CAT and GSR gene expression at early time 
points, ROS measurement at early time point of less than 24 hours would be recommended 
as well as looking at other markers of oxidative stress. Also, an in-depth study of the 
membrane potential and permeabilization of the mitochondria as a means of trying to proffer 
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Chapter 2: Materials and Method 
Calculation of concentration of gold nanoparticles used in this thesis 
(AuNP) 
 
Mass of HAuCl4.3H2O = 0.008g (amount weighed) 
49 % Au by assay   = Mass of Au  
     = 0.49 x 0.008 
     = 3.92 x 10-3 g 
   
No of moles of Au   = (3.92 x 10-3 g) / (197) 
    = 1.98 x 10-5 moles 
 
 [Au]    = 1.98 x 10-5 moles / 0.125 dm3 (total volume in flask)  
    = 1.59 x 10-4 M 
 
Number of Atoms per 13nm AuNP (Assuming that particles are spherical and estimated 
atomic radius of gold = 140 pm 
      = (6.5 x 10-9)3 / (140 x 10-12)3 
       = 100081.9971 
 
Concentration of AuNP = 1.59 x 10-4 / 100081.9971  
      = 1.6 x 10-9 
      
= 1.6 nM  
A. Ruthenium (RuS12) Synthesis  
RuS12 was prepared by Shani Osborne (Osborne & Pikramenou, 2015) using published data 
(Adams et al., 2014; Bertoncello et al., 2006; Rogers et al., 2014). The counter ion was 
exchanged using Dowex ® 1X8 ion exchange chromatography and the final solutions to be 
used for coating were prepared in methanol, 0.95 mM. This was followed by sonication with 





























Luminescence lifetime decay of RuS12·AuNP20: increase in 71% is observed on the addition 
of AuNP to probe.   
This experiment was done by Shani Osbourne and published in Osborne (Osborne & 
Pikramenou, 2015).   
 
C. Steps in quantification of confocal images by ImageJ 
1. Images acquired from the Red Channel are converted to 16-bit image to remove 
colour.  
2. The 16-bit image undergoes thresholding, which is done using the threshold 
function of imageJ. This is done automatically using the default setting which aims to gets a 
close resemblance of the initially fluorescent image from the red channel to the binary 
images.  
3. The binary image is analysed using the analyse particle tools on Image J 
4. This counts the black dots on the binary images that has a circularity of 0-1 and 
shows the outline of the count.  
5. A summary table is obtained that shows the count, total area, average size, % area 
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Chapter 3: Characterization of RuS12·AuNP20 and Uptake in A549 
cells 
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Figure 47: Representative merged confocal images of major time points of fixed A549 treated with 0.9 
nM RuS12·AuNP20 and Hoechst. 
A549 cells were treated with 0.9 nM RuS12.AuNP20 between 2-72 hours. The images shown are representative 
of all time points. This experiment was done as a biological triplicate, the first two duplicate were used to 
optimize imaging conditions and showed similar result with the third replicate which are the images reported.  
c. Merged images of RuS12·AuNP20 and Hoechst  
d. Their corresponding reflection image (λexc = 488 nm, λ =em = 478-498 nm) a 
e. Merged fluorescence and reflection channel.  
RuS12·AuNP20 emission form red channel (λexc = 488 nm, λem = 620-800 nm) 
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B. RuS12 alone in cells  
 
Figure 48: A549 cells treated with 0. 63 nM RuS12 alone for 4 hours  
 
RuS12 emission form red channel (λexc = 458 nm, λem = 620-800 nm) 





C. ICP-MS Standard curve  
A.  Gold standard curve  
 
B. Ruthenium Standard curve  
 
Figure 49: Standard curve of Au and Ru used for ICP-MS  
The standard curve were prepared using a series of standard solutions (0, 0.2, 0.5, 1, 2, 5, 10, 20 ppb) 
containing metals to be detected (A. gold and B. ruthenium). Standard was used for calibration and 






























Figure 50: ICP-MS measurement of uptake of 0.9 nM RuS12·AuNP20 in A549 cells 
Cells were treated with 0.9 nM RuS12·AuNP20 and at the end of each time points, cells were 
digested with aqua regia. The digested samples were used for ICP-MS analysis to determine 
intracellular concentration of ruthenium. Result presented is biological triplicate with three 
technical triplicate.  
 












D. Inhibition of Endocytic Uptake  
 
Method  
Two endocytosis inhibitors were employed namely: Chlorpromazine and 5-(N-Ethyl-N-
isopropyl) amiloride (EIPA) to study inhibition of endocytic uptake. Firstly, the cytotoxicity 
potential of both drugs on A549 cells were assessed using MTT assay. Chlorpromazine (5 
mM)  and EIPA (5 mM) stock solutions cytotoxic potential on A549 cells was tested by 
treating cells for 30 minutes with concentrations ranging from 10 µm -10 0µm to obtain a 
non-toxic concentration for further studies.  
Alexa Fluor® 488 conjugated transferrin from human serum (hTF-488) from Molecular 
probes and fluorescein-conjugated dextran (FITC-dextran 70 kDA) were used as positive 
control for clathrin dependent and macropinocytosis endocytosis respectively. Titrations of 
different dilutions (1:250, 1:500, 1:1000, 1:2000, 1:4000, 1:8000 and 1:10000) and 
concentrations (0.1 mg/ml, 0.2 mg/ml, 0.5 mg/ml, 1 mg/ml and 2 mg/ml ) of stock solution 
of hTF-488 and FITC-dextran70 respectively were treated with A549 cells for 30 minutes 
for hTF-488 and 60 minutes for  FITC-dextran 70 kDa. This was done to optimize condition 
that showed suitable cellular uptake in A549 cells without been saturated. Optimization was 
done by flow cytometry. Briefly, cells were seeded at a density of 100,000 cells per well in 
a 6-well plate and left overnight for attachment to occur. Spent media was aspirated and cell 
pre-treated with 3ml of a media containing either 1.25 µg/ml of hTF-488 or 2mg/ml of FITC-
dextran70 for 30 minutes followed by the addition of 50 µm Chlorpromazine and 50 µm 
EIPA for a further 30 minutes. 
At the end of each time point, spent media was removed and cells washed three times with 
1ml of PBS. Cells were detached by treating with 1ml of trypsin for 10 minutes and 
centrifuged for 10 minutes at 1500g. Cell pellets were re-suspended in fresh 1ml of PBS and 
transferred to flow cytometry tubes for analysis (FACScalibur, BD Biosciences USA). 
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Forward scatter, side scatter and fitc fluorescence (exc=488 nm with light collected through 
a 670 nm band pass filter) of 10,000 cells were collected and Weasel freeware 3.2.1 software 
was used for data analysis. 
 
Result 
The result presented is 30 minutes treatment of A549 cells with CPZ and EIPA, 30 minutes 
was chosen as a suitable time of treating cells based on published evidence (Brandenberger 
et al., 2010; Kuhn et al., 2014). Both inhibitor showed a concentration dependent decrease 
in cell viability, which was more pronounced in cells treated with CPZ, compared to cell 
treated with EIPA. With these result in mind, we aimed to test the ability of these inhibitors 
(although they showed evidence of cytotoxicity Figure 51) to inhibit the positive controls. 
The FITC florescence of positive controls were measured by flow cytometry after 30 minutes 
treatment, which is suitable for cellular uptake. The mean fluorescence shown in was 
obtained from the FITC histogram (Figure 52). The result showed that FITC-dextran showed 
very little fluorescence which increased in a concentration dependent. The unexpected result 
obtained was not conclusive enough to establish optimization inhibition study. Therefore, 






                   
 
B.  
                       
Figure 51: Cell viability of A549 cells treated with endocytic inhibitors  
Both inhibitors were treated with different concentration for 30 minutes and cell viability was 
measured by MTT assay. The experiment was biological triplicate (n=3) and result was presented as 
% control of mean absorbance ±SEM. The result showed a statistically significant *(p ≤ 0.05) difference 















































    
A. 
 
Figure 52: FITC fluorescence of positive control of endocytic inhibitors 
A549 cells were treated with various concentration of GFP-tagged transferrin and FITC-
tagged dextran for 30 minutes. The fluorescence was gotten from the histogram plot by FACS 
Aria, the result is expressed as mean fluorescence of treated-mean fluorescence of control. 



























Chapter 4: Localisation and Cellular Fate of RuS12·AuNP20 in A549 
cells 
Representative images for all time points used in studying co-localisation in all six 
organelles.  
R. RuS12·AuNP20 emission form red channel (λexc= 488 nm, λem = 620-800 nm). 
G. GFP emission form green channel (λexc= 488 nm, λem= 502 nm) 
B. Hoechst emission form the blue channel (λexc= 405 nm, λem= 410-455 nm) 
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Figure 53: Representative image of fixed A549 treated with 0.9 nM RuS12·AuNP20 and stained with 
Golgi ID 
The image shown is a representative image of A549cells treated with 0.9 nM RuS12·AuNP20 between 
4-24 hours. This experiment was done as a biological duplicate and images were all similar, showing 
no co-localisation betwwen the particle and the golgi at any time point.    
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Figure 54: Representative image of fixed A549 treated with 0.9nM RuS12·AuNP20 and stained with 
with MitoGreen 
The image shown is a representative image of A549cells treated with 0.9nM RuS12·AuNP20 
between 4-24 hours. This experiment was done as a biological duplicate and images were all 
similar, showing no co-localisation between the particles and the mitochondria at any time point.   
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Figure 55: Representative image of fixed A549 treated with 0.9nM RuS12·AuNP20 and stained with 
ER-tracker green.  
The image shown is a representative image of A549cells treated with 0.9nM RuS12·AuNP20 for 24 
hours. This experiment was done as a biological duplicate and images were all similar, showing no 
co-localisation betwwen the particle and the ER at any time point.  
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Figure 56 Representative image of fixed A549 transitenty transfected with GFP-RAB4 and treated with 
0.9 nm of RuS12·AuNP20.  
The image shown is a representative image of A549cells treated with 0.9nM RuS12·AuNP20 between 
4-24 hours after 48 hours post-transfection with GFP-RAB4. This experiment was done as a biological 
duplicate and images were all similar within time point.  
4 hours R 4 hours G 4 hours M 
8 hours R 8 hours G 8 hours M 
12 hours R 12 hours G 12 hours M 
16 hours R 16 hours G 16 hours M 







4 hours R 4 hours G 4 hours M 
8 hours R 8 hours G 8 hours M 
12 hours R 12 hours G 12 hours M 
16 hours R 16 hours G 16 hours M 
 182 
 
Figure 57: Representative image of fixed A549 transitenty transfected with GFP- LAMP1. 
The image shown is a representative image of A549 cells treated with 0.9 nM RuS12·AuNP20 
between 4-24 hours after 48 hours post-transfection with GFP-LAMP1. This experiment was done as 
a biological duplicate and images were all similar within time points. Increases time dependent co-
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Figure 58: Representative image of fixed A549 transitenty transfected with GFP-LC3.  
The image shown is a representative image of A549 cells treated with 0.9 nM 
RuS12·AuNP20betwwen 4-24 hours, after 48 hours post-transfection with GFP-LC3. This experiment 
was done as a biological duplicate and images were all similar within time points. Result showed 
increase in co-localisation over time.  
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G. Steps in co-localisation study by ImageJ to find the PCC.  
RGB images is spilt to individual channel and ready for co-loclaisation study using the 
Just Another Co-Loclaisation Plugin (JaCOP) on image.  
This plugin is capable of analysis images and getting the Pearson’s coefficient. This is 
done by comparing two different fluorescent channels. Which in our case was the red 
and green channel.  
Images from both channels is first threshold before analyzing. This is done 
automatically A summary data is obtained that shows the Pearson's Coefficient.  An 
example of the summary is shown below with the Pearson's Coefficient 
 
 
Image A: 16hours threshold (red).tif 
Image B: 16hours threshold (green).tif 
Pearson's Coefficient: r=0.328 
  
 Red  Green  Merged 
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Chapter 5: Cytotoxicity of RuS12·AuNP20 on A549 cells.  
All graphs shown in this section have been previously shown in chapter 5 without the 
positive control. The positive control was added here to validate the experiment. The positive 
control was not shown previously because it makes it difficult to see the difference between 
the treated and the control.   
 
A. MTT Assay  
i. RuS12·AuNP20 with positive Control 
 
Figure 59: MTT Assay on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours 
The experiment is a biological triplicate (n=3) and presented as % control of mean value ± SEM. 
The positive control was was 0.15% (v/v) Triton X-100 with media, which resulted in about 90% cell 
death   The result showed no statistically significant (p≤0.05) difference by one-anova and 
Bonferroni Post Hoc analysis between treated and control cells irrespective of length of exposure  
ii.RuS12 alone  
 
Figure 60: MTT Assay on A549 treated with RuS12 alone for 24 hours 
The experiment is a biological triplicate (n=3) and presented as % control of mean value ± SEM. 
The result showed no statistically significant (p≤0.05) difference by one-anova and Bonferroni Post 



























































B. CVS Assay of RuS12·AuNP20 with positive Control 
 
Figure 61: CVS on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours   
The experiment is a biological triplicate (n=3) and presented as % control of mean value ± SEM. The 
positive control used was 0.15% (v/v) Triton X-100 with media, which resulted in about 60% cell 
death. The result showed a statistically significant *(p ≤ 0.05) difference by one-anova and 
Bonferroni Post Hoc analysis between treated and non-treated control at 24 hours irrespective of 
concentration.  
C. H2DCF-DA Assay of RuS12·AuNP20 with positive Control 
 
Figure 62: DCFH-DA Assay on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours   
The experiment is a biological triplicate (n=3) and presented as % control of mean value ± SEM. A549 
cells treated with hydrogen peroxide (200 µm) were used as positive control and showed 60% 
increase in fluorescence intensity. The result showed an increasing trend in a concentration and 
time-dependent manner that leads to ROS generation but this was not statistically significant by 
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D. GSH ASSAY 
i) Standard Curve  
 
Figure 63: Standard curve of GSH used for GSH Assay.  
 
ii) Result of RuS12·AuNP20 with positive Control 
 
Figure 64: GSH Assay on A549 treated with RuS12·AuNP20 for 24, 48 and 72 hours   
The experiment is a biological triplicate (n=3) and presented as % control of mean value ± SEM. 
A549 cells treated with hydrogen peroxide (200 µm) was used as positive control and a 50% 
difference decrease of glutathione is observed when compared to the non-treated control. 
Generally, a time-dependent decrease in glutathione levels was observed irrespective of 
concentrations following treatment with RuS12·AuNP20 when compared to the non-treated control.  
However, this was only statistically significant *(P ≤ 0.05) following treatment with 0.9 nM and 0.45 

































































E. Alkaline Comet Assay of RuS12·AuNP20 with positive Control 
 
 
Figure 65: Median Tail intensity of A549 cells on exposure to RuS12·AuNP20 
The experiment is a biological triplicate (n=3) and presented as % control of mean value ± SEM. A549 
cells treated with 200 µm of hydrogen peroxide (positive control) for 1 hour, showed extreme 
unwinds indicating the formation of DNA-strand break. The result showed a statistically significant 
* (p ≤0.05) difference by one-anova and Bonferroni Post Hoc analysis between treated and non-
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